site aa pred_sec pred_expbur pred_accessibility pdb_asym_id hetero nucleotide compound metal otherpoly homo precipitant A C D E F G H I K L M N P Q R S T V W Y feature_table variant 1 M 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 2 L 0 0 0 0 0 0 0 0 0 60 0 0 0 0 0 40 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 3 T 40 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 60 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 4 L 0 0 0 0 0 0 0 0 0 80 0 0 20 0 0 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 5 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 60 40 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 6 T 0 0 0 0 0 0 0 29 0 28 0 0 0 0 0 0 43 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 7 W 0 0 0 0 0 0 28 0 0 0 0 0 0 0 0 0 0 0 72 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 8 L 1 0 1 1 1 1 0 1 1 59 0 1 1 1 1 1 1 26 0 1 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED L->V:LB/B:rs1063560: -; 9 V 14 0 1 1 1 1 0 1 1 2 13 1 1 1 1 1 20 39 0 1 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 10 Q 18 0 0 0 0 19 0 25 0 0 0 0 0 38 0 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 11 A 81 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 19 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 12 L 0 0 0 0 0 0 0 0 0 84 0 0 0 0 0 0 16 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 13 F 0 0 0 0 30 0 0 15 0 35 0 0 0 0 0 0 0 0 0 20 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 14 I 0 0 0 0 10 0 0 51 0 0 19 0 0 0 0 0 0 20 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 15 F 0 0 0 0 46 0 0 0 0 35 0 0 0 0 0 0 0 0 19 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 16 L 0 0 0 0 20 0 0 0 0 80 0 0 0 0 0 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 17 T 0 0 0 0 0 0 0 0 0 49 0 0 0 0 20 0 31 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 18 T 0 0 0 0 0 0 0 19 0 16 0 0 15 0 0 0 31 0 20 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 19 E 0 20 0 31 0 15 0 0 19 0 0 0 16 0 0 0 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 20 S 19 0 0 0 0 0 20 0 0 0 0 0 0 0 16 45 0 0 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 21 T 1 0 1 1 1 21 0 20 1 1 0 20 1 1 1 17 12 1 0 0 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 22 G 2 1 2 2 1 53 1 21 2 3 1 1 2 1 2 2 2 2 0 1 SIGNAL::SIGNAL::DISORDER:predicted by DISOPRED 23 E 2 1 21 13 1 2 1 22 2 3 1 1 2 21 2 2 2 2 0 1 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 24 L e 127.5 8d82_F Q98823_HHV8:IL6_HUMAN:I11RA_HUMAN:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-6[157 aa] 2 1 2 2 1 2 1 2 2 33 1 1 2 1 2 2 22 21 0 1 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 25 L e 88.8 8d82_F Q98823_HHV8:IL6_HUMAN:IL11_HUMAN:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-6[157 aa] 0 19 0 0 0 0 0 0 0 51 0 0 0 0 0 20 0 10 0 0 TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Extracellular" 26 D e 76.5 8d82_F Q98823_HHV8:IL6_HUMAN:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Interleukin-6[169 aa]:Interleukin-6[157 aa] 0 0 11 50 0 0 0 20 19 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 27 P e 27.1 8d82_F Q98823_HHV8:IL6_HUMAN:IL11_HUMAN:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-6[157 aa] 0 0 0 15 0 0 0 0 0 19 0 20 31 0 0 16 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DISORDER:predicted by DISOPRED:DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 28 C S e 21.3 8d82_F Q98823_HHV8:IL6_HUMAN:CSF3_HUMAN:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:CSF3[168 aa]:Interleukin-6[169 aa]:Interleukin-6[157 aa] 0 81 0 0 0 19 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 29 G E b 0.0 8d82_F 0 0 0 0 0 61 0 0 0 0 0 0 0 0 0 20 19 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 30 Y E e 43.9 8d82_F alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 0 0 0 0 30 0 0 0 0 0 0 0 0 0 0 19 20 31 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 31 I E b 0.0 8d82_F 0 0 0 0 0 0 0 55 0 0 0 0 0 0 0 0 13 33 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 32 S E e 53.1 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 0 25 19 0 0 0 0 0 0 0 0 0 0 30 0 13 0 13 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 33 P S e 47.3 8d82_F 0 0 0 0 0 0 0 9 0 0 0 0 73 10 0 0 0 8 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 34 E S e 44.2 8d82_F Q98823_HHV8:IL27A_HUMAN:IL27B_MOUSE:IL27A_MOUSE:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:IL6_HUMAN:VIRAL IL-6[167 aa]:Interleukin-27 subunit alpha[191 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-11[165 aa]:Interleukin-6[157 aa] 1 0 1 17 0 1 0 1 1 1 0 0 32 25 1 18 1 1 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 35 S S e 73.4 8d82_F Q98823_HHV8:IL27A_HUMAN:IL27B_MOUSE:IL27A_MOUSE:LIF_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:VIRAL IL-6[167 aa]:Interleukin-27 subunit alpha[191 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Leukemia inhibitory factor[169 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa] 14 0 22 0 9 9 0 0 19 0 0 0 8 0 0 19 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 36 P b 8.5 8d82_F 0 0 0 9 0 0 14 19 13 0 0 0 44 0 0 0 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 37 V B e 40.7 8d82_F 0 0 0 0 0 0 0 17 0 19 0 0 0 0 0 0 9 56 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 38 V b 18.7 8d82_F 0 0 0 0 9 0 0 34 0 9 0 0 0 0 0 0 19 29 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 39 Q e 52.0 8d82_F 0 0 0 0 0 0 7 0 0 29 0 0 7 23 8 26 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 40 L T b 16.3 8d82_F 0 0 0 0 0 0 0 9 0 40 9 0 0 0 9 0 0 33 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 41 H T e 66.5 8d82_F 0 0 0 0 0 95 5 0 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 42 S e 28.1 8d82_F 0 0 15 0 0 0 0 0 0 0 9 0 0 0 0 76 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 43 N e 57.0 8d82_F NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 13 0 13 0 0 0 0 0 0 0 0 43 15 0 0 9 7 0 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 44 F E b 5.3 8d82_F 12 0 0 0 14 0 0 25 0 9 0 0 0 0 0 0 0 40 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 45 T E e 45.5 8d82_F 0 0 0 0 0 0 0 0 0 8 0 21 0 9 0 29 34 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 46 A E b 0.0 8d82_F 37 0 0 0 33 0 0 30 0 0 0 0 0 0 0 0 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 47 V E e 30.7 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 19 0 0 0 0 14 5 0 0 0 0 0 0 0 28 20 5 0 9 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 48 C E b 0.0 8d82_F 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 49 V E e 39.3 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 0 0 0 0 0 26 0 0 0 0 0 9 0 29 8 27 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 50 L E b 5.6 8d82_F LEP_MOUSE:Leptin[140 aa] 0 0 0 9 0 0 0 23 0 35 0 0 0 0 0 7 7 0 0 19 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 51 K e 39.6 8d82_F IL6_HUMAN:Interleukin-6[163 aa] 9 0 0 0 0 0 9 0 61 0 0 0 0 13 0 8 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 52 E H e 78.9 8d82_F 0 0 0 27 0 9 0 0 4 9 0 15 22 14 0 0 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 53 K H e 67.9 8d82_F IL6_HUMAN:Interleukin-6[163 aa]:Interleukin-6[169 aa] 5 0 0 20 0 7 0 0 39 1 0 15 0 0 8 1 0 1 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 54 C H b 10.0 8d82_F IL6_HUMAN:Interleukin-6[163 aa]:Interleukin-6[169 aa] 1 50 1 1 1 1 0 1 1 2 0 20 1 1 1 1 1 14 0 1 DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 55 M H b 8.7 8d82_F 1 0 1 1 8 1 0 1 15 30 5 1 1 6 1 23 1 1 0 1 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 56 D H e 68.5 8d82_F 1 0 14 1 1 1 15 15 9 1 0 1 7 16 1 8 6 1 0 1 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 57 Y H e 67.8 8d82_F IL6RA_HUMAN:IL27B_HUMAN:IL6_HUMAN:Interleukin-6 receptor alpha chain[201 aa]:Interleukin-27 subunit beta[200 aa]:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-27 subunit beta[201 aa]:Interleukin-6[157 aa]:Interleukin-6 receptor subunit alpha[201 aa] 9 1 2 2 1 3 5 9 2 11 1 2 2 2 2 9 11 7 0 20 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 58 F H e 32.5 8d82_F IL6_HUMAN:IL6RA_HUMAN:Interleukin-6[163 aa]:Interleukin-6[169 aa]:Interleukin-6[157 aa]:Interleukin-6 receptor subunit alpha[201 aa] 3 1 2 3 7 10 1 2 3 10 1 2 18 2 2 17 3 3 1 10 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 59 H T e 62.8 8d82_F IL6RA_HUMAN:IL27B_MOUSE:IL27A_MOUSE:LIF_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:Interleukin-6 receptor alpha chain[201 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Leukemia inhibitory factor[169 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa] 2 1 1 2 1 11 29 1 2 2 1 1 1 8 9 20 2 2 0 5 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 60 V b 1.3 8d82_F 8 9 8 0 6 0 0 8 0 7 0 0 0 0 8 7 13 26 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 61 N e 38.2 8d82_F NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 7 0 0 0 0 0 0 0 0 47 4 8 9 17 8 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 62 A S b 3.6 8d82_F 22 13 0 7 0 0 0 0 8 1 0 0 17 8 0 21 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 63 N S e 69.1 8d82_F NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 8 0 0 16 0 1 0 0 27 8 0 5 14 0 10 5 5 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 64 Y S e 40.4 8d82_F NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 1 0 0 4 0 9 0 7 17 20 0 10 0 16 0 1 0 0 0 14 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 65 I b 2.3 8d82_F 1 0 0 0 0 1 0 69 0 25 0 0 0 0 0 1 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 66 V E e 25.3 8d82_F 1 0 0 0 0 1 13 0 0 29 0 0 0 0 0 1 0 34 0 18 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 67 W E b 0.0 8d82_F 1 0 0 0 10 1 0 0 7 14 0 0 0 0 0 1 0 0 57 7 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 68 K E e 28.3 8d82_F LEP_MOUSE:LEP_HUMAN:IL11_HUMAN:Leptin[141 aa]:Leptin[146 aa]:Interleukin-11[165 aa] 1 0 14 0 7 1 0 0 20 1 0 0 0 0 15 1 9 0 21 9 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 69 T b 18.2 8d82_F 1 0 0 0 7 14 0 0 10 24 17 0 0 0 4 1 14 7 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 70 N S e 54.5 8d82_F IL27A_HUMAN:IL27B_MOUSE:IL27A_MOUSE:LEP_MOUSE:LEP_HUMAN:CLCF1_HUMAN:IL6_HUMAN:Interleukin-27 subunit alpha[191 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-27 subunit alpha[177 aa] 1 0 6 12 0 7 0 0 0 1 0 52 0 7 0 11 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 71 H S e 96.9 8d82_F Q98823_HHV8:IL27B_MOUSE:IL27A_MOUSE:LEP_MOUSE:LEP_HUMAN:CLCF1_HUMAN:IL27A_HUMAN:IL11_HUMAN:IL6_HUMAN:VIRAL IL-6[167 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-27 subunit alpha[177 aa]:Interleukin-11[165 aa]:Interleukin-6[157 aa] 7 0 13 0 0 16 22 0 0 19 0 12 0 0 6 0 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 72 F e 64.1 8d82_F LEP_MOUSE:LEP_HUMAN:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa] 23 0 0 14 12 0 0 0 0 1 0 0 0 0 14 0 0 22 0 10 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 73 T B e 33.8 8d82_F 21 0 1 1 1 1 0 17 19 14 0 1 8 1 8 1 5 1 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 74 I b 6.4 8d82_F 1 0 1 1 1 1 0 53 1 9 0 1 1 7 1 1 1 15 0 6 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 75 P e 63.6 8d82_F 1 0 1 17 1 1 0 1 13 1 0 1 45 7 1 1 1 7 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 76 K S e 71.2 8d82_F 1 0 0 8 0 0 0 12 27 1 0 6 7 17 11 8 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 77 E S e 71.9 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 1 0 0 28 0 0 18 4 0 1 0 0 0 7 23 12 4 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 78 Q S e 27.6 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 0 13 0 11 7 0 0 7 0 11 0 47 0 0 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 79 Y b 17.0 8d82_F 0 0 0 0 6 0 19 17 6 0 0 0 0 0 6 7 6 7 0 25 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 80 T E e 43.5 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. 0 0 15 0 0 0 6 6 5 11 0 3 0 0 6 23 24 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 81 I E e 59.6 8d82_F 0 0 0 0 0 0 0 26 0 16 0 0 0 0 12 5 3 38 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 82 I e 38.0 8d82_F NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 0 0 5 5 0 0 4 20 0 19 0 0 5 7 0 13 0 21 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 83 N S e 73.9 8d82_F NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. 9 0 17 0 0 8 0 0 5 0 0 31 0 0 0 21 0 0 0 8 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 84 R S e 58.9 8d82_F LIF_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:Leukemia inhibitory factor[169 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 15 0 0 5 4 0 10 0 0 5 0 4 37 5 10 0 5 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 85 T S e 26.0 8d82_F LIF_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:Leukemia inhibitory factor[169 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. 0 0 0 5 8 0 12 0 0 6 0 0 0 5 3 15 35 11 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 86 A E b 4.5 8d82_F LIF_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:Leukemia inhibitory factor[169 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa] NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 6 0 4 12 0 14 4 3 4 0 0 0 0 16 0 0 25 12 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 87 S E b 1.6 8d82_F 16 0 0 5 0 4 4 0 0 5 0 6 0 0 14 32 9 5 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 88 S E b 9.4 8d82_F LIF_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:Leukemia inhibitory factor[169 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa] 5 0 0 7 0 6 0 5 14 4 0 15 0 0 23 22 0 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 89 V E b 0.0 8d82_F 0 0 0 0 0 0 0 22 0 16 0 0 4 0 0 5 0 43 0 7 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 90 T E e 26.6 8d82_F LIF_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:Leukemia inhibitory factor[169 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 5 0 0 0 0 0 4 0 6 4 0 4 0 0 0 5 43 15 11 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 91 F E b 14.4 8d82_F 0 0 0 0 49 4 0 7 0 15 0 0 0 0 0 0 0 0 5 16 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 92 T S e 63.0 8d82_F LIF_HUMAN:Leukemia inhibitory factor[169 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 5 0 0 7 6 0 4 0 11 7 0 0 12 4 0 6 31 6 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 93 D S e 69.8 8d82_F LIF_HUMAN:Leukemia inhibitory factor[169 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 1 0 16 11 1 6 14 1 1 1 0 32 1 5 4 1 4 1 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 94 I b 2.3 8d82_F 1 0 1 1 10 7 0 8 1 39 3 6 1 0 1 1 1 19 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 95 A e 77.7 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 9 0 1 1 1 1 7 1 6 7 0 21 1 10 7 11 11 6 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 96 S e 56.2 8d82_F 24 0 1 17 3 11 4 1 1 4 0 4 1 1 1 15 6 1 0 5 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 97 L S e 37.6 8d82_F LEP_MOUSE:Leptin[141 aa]:Leptin[140 aa] 1 0 1 1 1 1 0 1 1 23 0 1 13 3 1 5 15 13 0 20 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 98 N E e 53.9 8d82_F CLCF1_HUMAN:Cardiotrophin-like cytokine factor 1[178 aa] 1 0 13 1 1 1 10 1 1 1 0 24 1 21 11 10 1 1 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 99 I E b 16.4 8d82_F LEP_MOUSE:LEP_HUMAN:CLCF1_HUMAN:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Cardiotrophin-like cytokine factor 1[178 aa] 32 0 1 1 0 1 0 14 1 5 0 0 1 5 1 7 1 21 0 9 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 100 Q E e 35.2 8d82_F Q98823_HHV8:CSF3_HUMAN:IL23A_HUMAN:IL27A_HUMAN:IL27B_MOUSE:IL27A_MOUSE:IL6_HUMAN:IL11_HUMAN:VIRAL IL-6[167 aa]:CSF3[168 aa]:Interleukin-23 subunit alpha[137 aa]:Interleukin-23 subunit alpha[147 aa]:Interleukin-27 subunit alpha[191 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Interleukin-6[169 aa]:Interleukin-27 subunit alpha[177 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-23 subunit alpha[144 aa]:Interleukin-6[157 aa] 1 0 1 1 9 4 0 6 10 1 0 12 1 28 1 6 1 13 0 5 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 101 L E b 0.0 8d82_F LEP_MOUSE:LEP_HUMAN:CLCF1_HUMAN:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Cardiotrophin-like cytokine factor 1[178 aa] 1 0 7 1 4 1 0 1 1 23 14 1 1 1 1 5 1 26 0 13 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 102 T E b 18.8 8d82_F Q98823_HHV8:IL23A_HUMAN:IL27A_HUMAN:IL11_HUMAN:VIRAL IL-6[167 aa]:Interleukin-23 subunit alpha[147 aa]:Interleukin-27 subunit alpha[191 aa]:Interleukin-11[165 aa]:Interleukin-23 subunit alpha[144 aa] 1 13 1 1 8 5 5 1 1 4 0 1 1 7 4 5 33 4 0 6 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 103 C E b 0.0 8d82_F LEP_MOUSE:Leptin[141 aa] 7 57 5 0 0 16 0 0 0 10 0 0 0 0 0 1 0 1 0 0 DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 104 N E b 4.2 8d82_F Q98823_HHV8:IL23A_HUMAN:CLCF1_HUMAN:IL11_HUMAN:VIRAL IL-6[167 aa]:Interleukin-23 subunit alpha[137 aa]:Interleukin-23 subunit alpha[147 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-23 subunit alpha[144 aa] 2 0 1 1 4 1 6 1 17 2 0 41 7 1 1 1 11 1 0 1 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 105 I E b 2.9 8d82_F Q98823_HHV8:IL6_HUMAN:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Interleukin-6[169 aa] 23 4 0 22 0 1 0 8 0 25 0 0 0 0 0 1 0 7 0 6 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 106 L e 36.5 8d82_F LEP_MOUSE:LEP_HUMAN:CLCF1_HUMAN:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Cardiotrophin-like cytokine factor 1[178 aa] 10 4 0 10 0 1 8 7 0 21 6 0 0 5 0 1 6 9 0 9 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 107 T T b 5.2 8d82_F LEP_MOUSE:LEP_HUMAN:Leptin[140 aa]:Leptin[146 aa]:Leptin[141 aa] 5 30 4 8 0 7 0 10 4 1 0 10 5 0 0 6 8 1 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 108 F T e 62.7 8d82_F CSF3_HUMAN:IL12B_HUMAN:IL27B_HUMAN:IL27B_MOUSE:IL27A_MOUSE:LEP_MOUSE:LEP_HUMAN:IL6RA_HUMAN:I11RA_HUMAN:CSF3[168 aa]:Interleukin-12 subunit beta[303 aa]:Interleukin-27 subunit beta[200 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa]:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6 receptor subunit alpha[201 aa] beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 1 13 0 0 23 7 5 7 0 4 0 0 10 0 0 13 0 6 9 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 109 G S b 17.9 8d82_F IL12B_HUMAN:IL27B_HUMAN:IL27B_MOUSE:IL27A_MOUSE:LEP_MOUSE:LEP_HUMAN:I11RA_HUMAN:Interleukin-12 subunit beta[303 aa]:Interleukin-27 subunit beta[200 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Interleukin-11 receptor subunit alpha[283 aa] 5 0 1 5 1 35 13 1 6 1 0 7 1 1 10 7 6 1 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 110 Q S e 99.0 8d82_F IL23A_HUMAN:LEP_MOUSE:LEP_HUMAN:IL6RA_HUMAN:IL27B_HUMAN:I11RA_HUMAN:Interleukin-23 subunit alpha[137 aa]:Interleukin-23 subunit alpha[147 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-27 subunit beta[201 aa]:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa]:Interleukin-23 subunit alpha[144 aa]:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6 receptor subunit alpha[201 aa] 1 4 5 4 1 1 22 1 9 6 0 9 7 7 5 7 1 10 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 111 L S e 60.1 8d82_F IL6RA_HUMAN:IL12B_HUMAN:IL23A_HUMAN:IL27A_HUMAN:IL27B_MOUSE:IL27A_MOUSE:LEP_MOUSE:LEP_HUMAN:IL6_HUMAN:I11RA_HUMAN:Interleukin-6 receptor alpha chain[201 aa]:Interleukin-12 subunit beta[303 aa]:Interleukin-23 subunit alpha[147 aa]:Interleukin-27 subunit alpha[191 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-6[169 aa]:Interleukin-27 subunit alpha[177 aa]:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa]:Interleukin-12 subunit beta[302 aa]:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6[157 aa]:Interleukin-6 receptor subunit alpha[201 aa] 3 0 11 3 10 0 0 5 0 8 9 0 0 0 13 12 10 5 9 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 112 E e 38.7 8d82_F Q98823_HHV8:IL6_HUMAN:CSF3_HUMAN:IL23A_HUMAN:IL27A_HUMAN:LEP_MOUSE:LEP_HUMAN:LIF_HUMAN:IL11_HUMAN:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:CSF3[168 aa]:Interleukin-23 subunit alpha[137 aa]:Interleukin-23 subunit alpha[147 aa]:Interleukin-27 subunit alpha[191 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Leukemia inhibitory factor[169 aa]:Interleukin-6[169 aa]:Interleukin-27 subunit alpha[177 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-23 subunit alpha[144 aa]:Interleukin-6[157 aa] 9 0 10 22 0 7 0 0 0 4 0 3 0 9 0 16 0 4 0 12 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 113 Q E e 50.0 8d82_F Q98823_HHV8:IL6_HUMAN:IL6RA_HUMAN:CSF3_HUMAN:IL23A_HUMAN:IL27B_HUMAN:IL27A_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Interleukin-6 receptor alpha chain[201 aa]:CSF3[168 aa]:Interleukin-23 subunit alpha[137 aa]:Interleukin-23 subunit alpha[147 aa]:Interleukin-27 subunit beta[200 aa]:Interleukin-27 subunit alpha[191 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-27 subunit alpha[177 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-23 subunit alpha[144 aa]:Interleukin-6[157 aa]:Interleukin-6 receptor subunit alpha[201 aa] 12 0 16 16 0 0 0 9 4 0 0 0 0 25 0 7 0 9 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 114 N E e 64.8 8d82_F Q98823_HHV8:IL6_HUMAN:CSF3_HUMAN:LIF_HUMAN:IL23A_HUMAN:IL27A_HUMAN:IL27B_MOUSE:IL27A_MOUSE:CLCF1_HUMAN:IL11_HUMAN:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:CSF3[168 aa]:Leukemia inhibitory factor[180 aa]:Interleukin-23 subunit alpha[137 aa]:Interleukin-23 subunit alpha[147 aa]:Interleukin-27 subunit alpha[191 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-27 subunit alpha[177 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-23 subunit alpha[144 aa]:Interleukin-6[157 aa] 6 0 6 11 0 8 5 7 0 4 0 23 0 6 9 7 8 0 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 115 V E b 10.7 8d82_F Q98823_HHV8:IL6_HUMAN:CSF3_HUMAN:LIF_HUMAN:IL27B_MOUSE:IL27A_MOUSE:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:CSF3[168 aa]:Leukemia inhibitory factor[180 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Leukemia inhibitory factor[169 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-6[157 aa] 0 0 0 2 4 0 0 24 7 25 3 0 0 0 0 0 3 31 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 116 Y E e 27.8 8d82_F Q98823_HHV8:IL6_HUMAN:CSF3_HUMAN:IL27A_HUMAN:IL27B_MOUSE:IL27A_MOUSE:IL11_HUMAN:IL12A_MOUSE:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:CSF3[168 aa]:Interleukin-27 subunit alpha[191 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Interleukin-6[169 aa]:Interleukin-27 subunit alpha[177 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-12 subunit alpha[156 aa]:Interleukin-6[157 aa] 4 18 7 0 16 0 0 0 4 3 0 0 0 0 2 0 0 14 0 29 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 117 G E e 45.2 8d82_F Q98823_HHV8:IL6_HUMAN:CSF3_HUMAN:LIF_HUMAN:IL23A_HUMAN:IL27A_HUMAN:IL27B_MOUSE:IL27A_MOUSE:CLCF1_HUMAN:IL11_HUMAN:IL12A_MOUSE:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:CSF3[168 aa]:Leukemia inhibitory factor[180 aa]:Interleukin-23 subunit alpha[137 aa]:Interleukin-23 subunit alpha[147 aa]:Interleukin-27 subunit alpha[191 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Leukemia inhibitory factor[169 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-12 subunit alpha[156 aa]:Interleukin-12 subunit alpha[154 aa]:Interleukin-23 subunit alpha[144 aa]:Interleukin-12 subunit alpha[157 aa]:Interleukin-6[157 aa] 0 0 0 0 0 74 2 0 0 0 0 3 0 7 0 0 0 11 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 118 I E b 6.4 8d82_F LIF_HUMAN:IL23A_HUMAN:IL12A_MOUSE:Leukemia inhibitory factor[180 aa]:Interleukin-23 subunit alpha[137 aa]:Interleukin-23 subunit alpha[147 aa]:Interleukin-12 subunit alpha[154 aa] 10 0 0 0 0 0 0 30 7 0 0 0 0 0 5 3 16 29 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 119 T E e 47.4 8d82_F LIF_HUMAN:IL23A_HUMAN:IL27A_HUMAN:IL27B_MOUSE:IL27A_MOUSE:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:IL12A_MOUSE:Leukemia inhibitory factor[180 aa]:Interleukin-23 subunit alpha[137 aa]:Interleukin-23 subunit alpha[147 aa]:Interleukin-27 subunit alpha[191 aa]:Interleukin-27 subunit beta,Interleukin-27 subunit..:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-11[165 aa]:Interleukin-12 subunit alpha[156 aa]:Interleukin-12 subunit alpha[154 aa]:Interleukin-23 subunit alpha[144 aa]:Interleukin-12 subunit alpha[157 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 3 17 15 0 7 5 0 0 4 0 0 5 0 7 2 16 19 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 120 I E b 1.8 8d82_F 0 0 0 0 0 0 0 30 0 41 2 0 0 0 5 0 4 18 0 0 DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Ig-like C2-type":TOPO_DOM:/note="Extracellular" 121 I E e 38.6 8d82_F CNTF_HUMAN:CLCF1_HUMAN:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa] 0 0 0 8 22 0 3 5 2 17 0 9 4 4 7 16 0 0 0 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 122 S b 0.0 8d82_F 17 0 0 4 0 2 0 9 2 6 0 2 0 0 0 22 0 35 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 123 G b 0.0 8d82_F 0 3 10 0 0 62 0 0 0 0 0 9 0 0 0 12 0 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 124 L e 25.8 8d82_F SO4 3 0 4 0 1 0 3 8 11 13 0 3 0 3 0 4 0 24 0 23 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 125 P e 27.9 8d82_F 4 0 0 0 0 0 0 3 0 0 0 0 75 0 0 7 0 10 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 126 P b 10.9 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 7 0 3 0 0 0 0 0 7 0 0 76 0 0 5 0 0 0 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 127 E e 41.7 8d82_F CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 14 0 15 35 0 9 0 0 4 0 0 0 0 0 2 19 3 0 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 128 K e 39.6 8d82_F IL6RB_HUMAN:H4H25311P2 antibody Fab fragment light chain[215 a..:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 18 0 0 18 0 3 0 8 19 0 0 0 7 5 7 2 9 4 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 129 P b 2.3 8d82_F 0 0 7 0 0 0 0 0 0 0 0 0 90 0 0 0 0 3 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 130 K E e 59.0 8d82_F NAG CL 0 0 3 12 3 9 2 0 13 3 0 0 0 20 5 7 13 10 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 131 N E e 75.8 8d82_F LEP_MOUSE:LEP_HUMAN:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 1 0 3 11 1 1 2 9 7 4 0 47 1 2 1 1 3 1 0 6 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 132 L E b 15.7 8d82_F LEP_MOUSE:LEP_HUMAN:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL 2 0 0 0 7 0 1 14 0 45 5 0 2 0 0 0 1 24 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 133 S E e 48.4 8d82_F LEP_MOUSE:LEP_HUMAN:antibody heavy chain[220 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL:CO3:ACT 2 2 0 2 0 0 0 6 13 0 0 3 3 5 0 50 12 2 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 134 C E b 6.0 8d82_F GOL:CO3 8 71 0 0 7 0 0 0 0 3 0 0 0 0 2 4 0 3 0 0 DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 135 I E b 19.3 8d82_F antibody heavy chain[220 aa]:antibody heavy chain[227 aa] GOL:CO3 0 0 0 19 10 0 0 11 0 10 2 7 0 4 12 7 0 11 2 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 136 V E b 0.0 8d82_F antibody heavy chain[227 aa] 12 0 0 0 3 3 0 12 8 1 4 2 0 2 8 15 16 9 3 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 137 N E e 28.5 8d82_F antibody heavy chain[220 aa]:antibody heavy chain[227 aa] NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 6 0 0 3 3 7 10 2 7 1 0 22 11 0 6 0 6 5 0 11 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 138 E S b 19.6 8d82_F antibody heavy chain[220 aa]:antibody heavy chain[227 aa] NAG GOL:SO4 1 0 21 25 3 2 0 0 3 1 0 9 7 3 0 7 11 1 0 4 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 139 G S e 89.3 8d82_F SOMA_HUMAN:IL6_HUMAN:PRL_HUMAN:LEP_HUMAN:IL11_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:Interleukin-6[163 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:Leptin[100 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 1 0 3 1 7 10 0 3 13 14 2 2 11 2 6 13 5 1 0 5 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 140 K S e 69.8 8d82_F SOMA_HUMAN:CSH_SHEEP:IL6_HUMAN:PRL_HUMAN:LEP_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PLACENTAL LACTOGEN[183 aa]:Interleukin-6[163 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:antibody heavy chain[220 aa]:antibody heavy chain[227 aa]:Leptin[100 aa]:Leptin[94 aa] NAG 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-al.. 1 0 3 18 0 15 0 0 24 1 0 5 0 0 3 12 13 4 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 141 K e 47.6 8d82_F antibody heavy chain[220 aa]:antibody heavy chain[227 aa] NAG NA 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL 6 0 2 7 0 4 0 0 7 0 0 23 0 3 0 12 29 0 0 5 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 142 M E b 2.9 8d82_F NA 3 3 0 0 21 0 0 10 0 20 26 0 0 0 0 0 0 17 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 143 R E e 24.5 8d82_F antibody heavy chain[220 aa]:antibody heavy chain[227 aa] NA 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-al.. GOL:SO4 8 0 2 0 2 2 2 13 3 8 0 5 0 0 4 7 32 10 0 4 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 144 C E b 0.0 8d82_F 0 78 0 0 0 0 0 0 0 14 0 0 0 0 0 0 0 7 0 0 DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 145 E E e 33.2 8d82_F antibody heavy chain[220 aa]:antibody heavy chain[227 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL:CO3:ACT 0 0 0 18 0 0 0 0 0 2 0 0 3 6 11 19 30 0 10 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 146 W E b 5.6 8d82_F NA 0 0 0 0 0 0 0 3 0 1 0 0 0 0 0 0 0 0 96 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 147 D E e 60.5 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 3 0 14 12 0 0 7 0 6 3 0 21 0 3 6 22 2 0 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 148 G e 27.4 8d82_F 7 0 0 0 0 20 0 0 0 4 0 3 51 0 5 5 5 0 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" G->R:LB/B:rs2228044: -; 149 G e 46.4 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. 0 0 0 3 0 69 0 0 0 3 0 1 6 0 0 14 0 3 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 150 R S e 45.8 8d82_F SO4 10 0 0 0 0 0 0 2 15 5 0 0 7 3 30 12 9 5 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 151 E e 77.9 8d82_F 0 0 21 27 0 1 0 9 4 3 0 5 7 0 2 5 5 10 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 152 T b 14.3 8d82_F SO4 0 0 9 0 0 13 4 0 2 4 0 0 8 2 0 9 47 0 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 153 H S e 40.8 8d82_F SO4 6 0 0 2 2 23 10 3 0 4 0 7 0 7 2 10 7 3 0 12 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 154 L S b 11.2 8d82_F IL12A_MOUSE:Interleukin-12 subunit alpha[156 aa]:Interleukin-12 subunit alpha[157 aa] 1 0 1 1 0 1 3 13 1 51 0 1 6 0 1 3 12 1 0 5 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 155 E e 62.3 8d82_F IL12A_MOUSE:Interleukin-12 subunit alpha[156 aa]:Interleukin-12 subunit alpha[154 aa]:Interleukin-12 subunit alpha[157 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 5 0 10 9 0 0 2 0 4 3 0 6 24 9 2 7 5 0 0 14 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 156 T e 20.1 8d82_F 0 0 0 0 0 4 0 0 0 5 0 6 4 7 3 4 57 7 0 4 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 157 N E e 27.3 8d82_F H4H25311P2 antibody Fab fragment heavy chain[217 a.. NAG beta-D-mannopyranose-(1-4)-beta-D-mannopyranose-(1..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 6 0 0 6 0 0 2 3 8 4 0 25 0 4 13 18 4 4 0 4 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 158 F E b 12.9 8d82_F 3 0 0 0 12 7 0 7 0 8 0 0 2 0 0 0 0 3 0 57 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 159 T E b 15.6 8d82_F H4H25311P2 antibody Fab fragment heavy chain[217 a.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 2 9 2 0 0 0 4 2 3 14 0 3 0 0 3 6 45 6 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 160 L E b 1.1 8d82_F LEP_MOUSE:Leptin[141 aa]:Leptin[140 aa] 0 0 0 6 0 0 0 8 6 48 2 0 0 0 7 0 7 13 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 161 K E e 32.1 8d82_F SOMA_HUMAN:CSH_SHEEP:PRL_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PLACENTAL LACTOGEN[183 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:H4H25311P2 antibody Fab fragment heavy chain[217 a.. NAG NI 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 1 0 1 10 6 1 6 1 31 3 0 1 2 7 11 7 5 1 0 8 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 162 S E b 3.9 8d82_F SOMA_HUMAN:PRL_HUMAN:LEP_HUMAN:LEP_MOUSE:IL11_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:Prolactin[165 aa]:Prolactin[186 aa]:Leptin[100 aa]:Leptin[94 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Interleukin-11[164 aa] 8 9 3 5 2 10 0 1 1 4 0 0 1 2 6 23 5 8 0 12 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 163 E E e 29.1 8d82_F LIF_HUMAN:LEP_HUMAN:LEP_MOUSE:IL11_HUMAN:IL6RB_HUMAN:Leukemia inhibitory factor[169 aa]:Leptin[100 aa]:Leptin[94 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:H4H25311P2 antibody Fab fragment light chain[215 a..:H4H25311P2 antibody Fab fragment heavy chain[217 a..:Interleukin-11[164 aa]:Interleukin-6 receptor subunit beta[298 aa] alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 3 0 9 15 1 5 0 4 10 8 0 1 4 5 6 20 3 5 0 3 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 164 W e 44.6 8d82_F SOMA_HUMAN:Q98823_HHV8:IL6_HUMAN:LIF_HUMAN:LEP_HUMAN:LEP_MOUSE:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Leukemia inhibitory factor[169 aa]:Leptin[100 aa]:Leptin[94 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-6[157 aa] 2 0 5 7 5 3 5 1 11 9 0 1 1 2 1 5 8 1 15 18 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 165 A S e 88.4 8d82_F LIF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:Leukemia inhibitory factor[169 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa] 13 6 4 10 5 11 0 4 6 8 0 1 4 5 4 10 2 4 0 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 166 T S e 82.5 8d82_F Q98823_HHV8:LIF_HUMAN:CNTF_HUMAN:IL11_HUMAN:IL6_HUMAN:VIRAL IL-6[167 aa]:Leukemia inhibitory factor[169 aa]:Ciliary neurotrophic factor[174 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-6[157 aa] CO3 1 0 1 4 2 17 0 6 7 8 1 4 2 8 1 10 18 9 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 167 H e 52.9 8d82_F IL6_HUMAN:LIF_HUMAN:CNTF_HUMAN:IL11_HUMAN:Interleukin-6[163 aa]:Leukemia inhibitory factor[169 aa]:Ciliary neurotrophic factor[174 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa] 1 0 6 19 0 7 13 2 4 1 0 5 3 7 8 12 2 5 0 4 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 168 K e 75.9 8d82_F LIF_HUMAN:IL11_HUMAN:Leukemia inhibitory factor[169 aa]:Interleukin-11[165 aa] 0 2 2 16 0 4 2 0 31 5 0 4 2 6 15 2 7 0 0 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 169 F e 25.8 8d82_F CSF3_HUMAN:CNTF_HUMAN:IL11_HUMAN:IL6RB_HUMAN:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:Ciliary neurotrophic factor[174 aa]:Interleukin-11[165 aa]:Interleukin-6 receptor subunit beta[398 aa] 5 15 0 2 24 3 2 12 0 7 3 2 3 0 0 6 0 3 4 7 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 170 A e 42.9 8d82_F 7 2 2 9 0 5 3 0 8 6 2 3 13 9 0 6 7 8 3 7 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 171 D e 48.8 8d82_F IL6_HUMAN:IL6RB_HUMAN:antibody heavy chain[220 aa]:antibody heavy chain[227 aa]:Interleukin-6[169 aa]:Interleukin-6 receptor subunit beta[589 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO 2 3 32 12 0 2 0 0 6 5 0 12 3 7 4 4 6 2 2 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 172 C E b 5.3 8d82_F IL12A_MOUSE:Interleukin-12 subunit alpha[156 aa] NA EDO 4 44 0 2 2 3 1 2 0 6 0 2 0 2 0 11 8 5 0 8 MUTAGEN:/note="C->S: Induces ligand-independent activation.":DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="C->S: Induces ligand-independent activation.":DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 173 K E e 67.5 8d82_F IL12A_MOUSE:antibody heavy chain[220 aa]:antibody heavy chain[227 aa]:Interleukin-12 subunit alpha[156 aa] NAG 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-al.. EDO 2 0 3 17 0 6 2 4 10 4 0 7 8 5 3 10 9 6 0 5 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 174 A b 8.9 8d82_F antibody heavy chain[220 aa]:antibody heavy chain[227 aa] GOL 11 0 2 3 0 16 5 0 8 8 2 6 5 4 3 8 9 5 0 4 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 175 K e 75.0 8d82_F GOL 2 4 3 13 0 4 4 3 21 0 0 9 0 10 10 8 3 3 0 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 176 R S e 74.3 8d82_F NAG 2 0 2 7 0 2 2 4 9 4 3 8 2 3 18 15 13 2 0 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 177 D S e 98.8 8d82_F IL12A_MOUSE:antibody heavy chain[220 aa]:antibody heavy chain[227 aa]:Interleukin-12 subunit alpha[154 aa] 7 0 19 8 8 13 0 2 2 5 0 2 5 3 2 13 3 2 2 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 178 T e 37.7 8d82_F IL12A_MOUSE:antibody heavy chain[220 aa]:antibody heavy chain[227 aa]:Interleukin-12 subunit alpha[154 aa] NA GOL 5 2 2 0 9 14 0 8 0 3 0 4 1 11 2 9 12 9 3 3 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 179 P S e 46.5 8d82_F IL12A_MOUSE:antibody light chain[215 aa]:antibody heavy chain[220 aa]:antibody light chain[216 aa]:antibody heavy chain[227 aa]:Interleukin-12 subunit alpha[154 aa] 0 0 6 3 8 6 4 0 6 5 0 5 31 10 0 9 3 0 0 3 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 180 T S e 35.7 8d82_F NA EDO 7 0 0 4 5 1 6 2 6 4 0 22 0 3 3 6 16 3 5 6 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 181 S e 20.3 8d82_F NA GOL 4 4 0 6 0 8 0 0 0 5 0 9 8 13 11 25 3 3 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 182 C b 3.3 8d82_F GOL 0 50 0 4 2 0 0 6 2 11 0 0 0 4 0 11 5 3 0 0 DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 183 T B e 53.2 8d82_F LIF_HUMAN:Leukemia inhibitory factor[180 aa]:antibody heavy chain[220 aa]:antibody heavy chain[227 aa] NA 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-al..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL 6 2 0 7 2 0 6 9 0 0 4 0 4 7 4 22 10 9 0 8 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 184 V b 4.0 8d82_F PRL_HUMAN:Prolactin[185 aa]:Prolactin[186 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 2 2 5 3 11 9 0 13 4 13 3 0 6 7 0 2 0 10 0 8 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 185 D S e 69.8 8d82_F NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL 11 0 21 4 2 2 0 0 3 5 0 11 6 11 8 5 4 5 0 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 186 Y S b 14.8 8d82_F CSF3_HUMAN:CSF3[168 aa] NAG GOL 2 0 2 0 6 9 5 3 14 17 0 0 2 7 0 7 2 2 0 23 MUTAGEN:/note="Missing: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="Missing: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 187 S e 78.9 8d82_F Q98823_HHV8:IL6_HUMAN:LIF_HUMAN:PRL_HUMAN:LEP_MOUSE:LEP_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Leukemia inhibitory factor[169 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:INTERLEUKIN-6[160 aa]:INTERLEUKIN-6[152 aa]:Leptin[141 aa]:Leptin[146 aa]:Leptin[138 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-6[157 aa] CYS NA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. IL6RB_HUMAN:PROTEIN (GP130)[215 aa] GOL 4 1 12 5 2 7 2 0 6 12 3 6 2 11 2 10 10 3 0 2 MUTAGEN:/note="Missing: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="Missing: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 188 T e 22.7 8d82_F CSF3_HUMAN:CSH_SHEEP:Q98823_HHV8:PRL_HUMAN:LEP_HUMAN:LEP_MOUSE:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PLACENTAL LACTOGEN[183 aa]:VIRAL IL-6[167 aa]:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:Monoclonal antibody 9F8 fab fragment Heavy chain[2..:Leptin[100 aa]:Leptin[94 aa]:Leptin[102 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Leptin[138 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa] 7 0 6 9 7 0 4 6 6 14 0 4 8 1 6 10 12 0 0 0 MUTAGEN:/note="Missing: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="Missing: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 189 V e 37.3 8d82_F SOMA_HUMAN:CSF3_HUMAN:CSH_SHEEP:Q98823_HHV8:IL6RB_HUMAN:IL6_HUMAN:PRL_HUMAN:LEP_HUMAN:LEP_MOUSE:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:IL6RB_MOUSE:PROTEIN (GROWTH HORMONE)[186 aa]:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:PLACENTAL LACTOGEN[183 aa]:VIRAL IL-6[167 aa]:Interleukin-6 receptor beta chain[298 aa]:Interleukin-6[163 aa]:CSF3[168 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:INTERLEUKIN-6[160 aa]:Leptin[100 aa]:Leptin[94 aa]:Leptin[102 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Leptin[138 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-6[157 aa]:Interleukin-6 receptor subunit beta[584 aa] IL6RB_HUMAN:PROTEIN (GP130)[215 aa] 5 4 3 6 2 3 0 21 3 14 1 0 0 5 2 6 9 15 0 0 MUTAGEN:/note="V->G: Does not induce ligand-independent activation.":MUTAGEN:/note="Missing: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="V->G: Does not induce ligand-independent activation.":MUTAGEN:/note="Missing: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 190 Y e 22.6 8d82_F SOMA_HUMAN:CSF3_HUMAN:CSH_SHEEP:Q98823_HHV8:IL6_HUMAN:PRL_HUMAN:LEP_HUMAN:LEP_MOUSE:LIF_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:PLACENTAL LACTOGEN[183 aa]:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:CSF3[168 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:Monoclonal antibody 9F8 fab fragment Heavy chain[2..:Leptin[100 aa]:Leptin[94 aa]:Leptin[102 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Leptin[138 aa]:Leukemia inhibitory factor[169 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-6[157 aa] NA ACT 0 0 0 0 14 3 4 2 7 16 6 0 0 0 4 8 2 4 5 23 MUTAGEN:/note="Y->G: Does not induce ligand-independent activation.":MUTAGEN:/note="Missing: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="Y->G: Does not induce ligand-independent activation.":MUTAGEN:/note="Missing: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 191 F S e 69.9 8d82_F CSF3_HUMAN:CSH_SHEEP:Q98823_HHV8:IL6_HUMAN:LIF_HUMAN:PRL_HUMAN:LEP_HUMAN:LEP_MOUSE:CNTF_HUMAN:CLCF1_HUMAN:IL6RB_HUMAN:IL11_HUMAN:IL6RB_MOUSE:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:PLACENTAL LACTOGEN[183 aa]:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Leukemia inhibitory factor[169 aa]:CSF3[168 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:INTERLEUKIN-6[160 aa]:Leptin[100 aa]:Leptin[94 aa]:Leptin[102 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Leptin[138 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-6[157 aa]:Interleukin-6 receptor subunit beta[584 aa] IL6RB_HUMAN:PROTEIN (GP130)[215 aa] 0 0 3 2 22 2 11 4 5 12 2 5 0 0 4 0 6 4 5 15 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 192 V S b 20.0 8d82_F SOMA_HUMAN:CSF3_HUMAN:CSH_SHEEP:Q98823_HHV8:IL6_HUMAN:LIF_HUMAN:PRL_HUMAN:LEP_HUMAN:LEP_MOUSE:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:PLACENTAL LACTOGEN[183 aa]:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Leukemia inhibitory factor[169 aa]:CSF3[168 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:Leptin[100 aa]:Leptin[94 aa]:Leptin[102 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Leptin[138 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Interleukin-6[157 aa] 5 0 0 3 7 1 3 10 0 11 1 0 5 9 0 7 15 16 3 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 193 N e 55.8 8d82_F CSF3_HUMAN:IL6_HUMAN:LIF_HUMAN:LEP_HUMAN:LEP_MOUSE:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:Interleukin-6[163 aa]:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:Leukemia inhibitory factor[169 aa]:Leptin[100 aa]:Leptin[94 aa]:Leptin[102 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Leptin[138 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-11[164 aa]:Interleukin-6[157 aa] 1 2 4 3 0 9 0 0 3 5 0 18 2 9 0 14 16 3 0 9 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 194 I E b 3.5 8d82_F CO3 2 0 1 1 3 3 3 12 1 10 6 0 1 5 1 1 1 8 0 43 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 195 E E e 29.6 8d82_F LIF_HUMAN:IL13_HUMAN:IL6RB_HUMAN:Leukemia inhibitory factor[169 aa]:Interleukin-13[111 aa]:H4H25311P2 antibody Fab fragment light chain[215 a..:H4H25311P2 antibody Fab fragment heavy chain[217 a..:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. CO3 7 2 1 28 1 3 0 1 6 3 0 6 1 4 5 8 19 4 0 1 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 196 V E b 0.0 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. CO3 2 0 0 0 14 1 0 31 0 4 10 0 2 0 0 0 0 32 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 197 W E b 14.7 8d82_F H4H25311P2 antibody Fab fragment light chain[215 a..:H4H25311P2 antibody Fab fragment heavy chain[217 a.. 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 3 0 0 11 0 1 5 0 4 1 1 7 4 11 7 5 9 2 23 5 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 198 V E b 0.0 8d82_F 3 0 0 1 0 1 0 19 1 16 0 0 2 0 0 4 4 48 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 199 E E b 16.6 8d82_F H4H25311P2 antibody Fab fragment heavy chain[217 a.. NAG alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. 0 3 0 20 4 0 0 2 2 10 5 7 2 18 6 4 14 2 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 200 A E b 0.0 8d82_F 65 0 3 3 0 3 0 7 0 0 0 0 3 0 0 6 0 7 0 1 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" A->G:US:rs1999050: -; 201 E E e 42.7 8d82_F H4H25311P2 antibody Fab fragment heavy chain[217 a.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 7 0 3 23 5 0 1 7 2 0 3 5 8 4 6 5 12 8 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 202 N b 8.5 8d82_F H4H25311P2 antibody Fab fragment heavy chain[217 a.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 0 0 2 2 0 2 5 0 0 0 0 71 0 2 0 2 11 0 0 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 203 A S e 69.6 8d82_F NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 16 0 3 2 1 17 0 0 2 2 2 4 11 6 7 22 0 2 0 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 204 L S e 29.8 8d82_F SO4 5 2 4 0 8 0 0 6 0 44 7 2 2 2 0 0 1 16 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 205 G e 29.8 8d82_F H4H25311P2 antibody Fab fragment heavy chain[217 a.. 1 0 0 0 0 79 0 0 0 0 0 0 0 2 5 9 3 0 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 206 K E e 51.9 8d82_F H4H25311P2 antibody Fab fragment light chain[215 a..:H4H25311P2 antibody Fab fragment heavy chain[217 a.. NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. SO4 3 0 5 5 0 0 2 2 18 0 5 8 0 6 9 26 3 6 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 207 V E e 28.7 8d82_F SO4 9 0 1 5 0 7 0 6 6 19 0 4 1 2 4 18 5 11 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 208 T E e 32.5 8d82_F IL6RB_HUMAN:H4H25311P2 antibody Fab fragment light chain[215 a..:Interleukin-6 receptor subunit beta[298 aa] alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4 2 0 5 6 2 0 0 0 6 0 2 3 14 3 7 26 17 3 0 2 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 209 S b 5.5 8d82_F IL6RB_HUMAN:H4H25311P2 antibody Fab fragment light chain[215 a..:Interleukin-6 receptor subunit beta[298 aa] SO4 7 1 0 4 2 2 0 2 0 0 0 2 6 0 4 58 9 2 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 210 D e 68.5 8d82_F CSH_SHEEP:PLACENTAL LACTOGEN[183 aa]:H4H25311P2 antibody Fab fragment light chain[215 a.. 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 2 0 32 4 1 0 4 0 5 4 0 0 9 4 0 17 10 5 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 211 H e 55.5 8d82_F CSH_SHEEP:IL6RB_HUMAN:IL6RB_MOUSE:PLACENTAL LACTOGEN[183 aa]:H4H25311P2 antibody Fab fragment light chain[215 a..:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. CO3:SO4 6 0 3 4 0 5 9 2 6 4 2 6 25 7 0 10 5 5 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 212 I E e 38.0 8d82_F CSH_SHEEP:PLACENTAL LACTOGEN[183 aa] 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 3 0 0 2 3 0 3 23 2 21 0 2 0 4 7 2 9 18 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 213 N E e 63.0 8d82_F SOMA_HUMAN:CSH_SHEEP:IL6RB_HUMAN:LIF_HUMAN:PRL_HUMAN:CLCF1_HUMAN:IL11_HUMAN:IL6RB_MOUSE:PROTEIN (GROWTH HORMONE)[186 aa]:PLACENTAL LACTOGEN[183 aa]:Interleukin-6 receptor beta chain[298 aa]:Leukemia inhibitory factor[169 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-11[164 aa]:Interleukin-6 receptor subunit beta[584 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 4 9 7 0 0 0 7 2 6 9 0 8 3 0 3 14 10 5 0 10 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 214 F E b 11.0 8d82_F 7 0 4 1 25 1 0 13 1 15 0 0 1 0 4 2 3 18 4 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 215 D b 13.0 8d82_F SOMA_HUMAN:CSF3_HUMAN:CSH_SHEEP:IL6_HUMAN:LIF_HUMAN:PRL_HUMAN:LEP_MOUSE:CNTF_HUMAN:CLCF1_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PLACENTAL LACTOGEN[183 aa]:Interleukin-6[163 aa]:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:Leukemia inhibitory factor[169 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:Leptin[140 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[157 aa] CYS:NAG alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 5 0 26 12 0 1 3 1 0 9 0 13 2 5 9 4 6 5 0 0 MUTAGEN:/note="D->G: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="D->G: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 216 P T b 2.3 8d82_F 9 0 8 4 3 3 0 7 0 13 2 2 23 0 2 3 6 13 0 0 DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 1":TOPO_DOM:/note="Extracellular" 217 V T b 4.7 8d82_F SOMA_HUMAN:CSF3_HUMAN:CSH_SHEEP:PRL_HUMAN:LEP_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:PLACENTAL LACTOGEN[183 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:Leptin[102 aa]:Leptin[146 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa] CYS:NAG NA alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 3 1 5 4 2 0 0 19 2 11 6 0 3 6 0 1 18 12 0 5 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 218 Y T e 32.2 8d82_F SOMA_HUMAN:CSH_SHEEP:IL6_HUMAN:CSF3_HUMAN:PRL_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PLACENTAL LACTOGEN[183 aa]:Interleukin-6[163 aa]:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa] NAG NA alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. EDO 6 2 11 11 0 3 5 0 4 5 0 2 2 3 1 16 2 13 0 14 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 219 K S e 31.1 8d82_F CO3 0 0 6 3 0 1 0 23 10 3 2 2 2 7 17 4 8 10 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 220 V E b 2.0 8d82_F IL6RA_HUMAN:Interleukin-6 receptor subunit alpha[14 aa] 6 0 4 6 1 6 0 5 0 5 3 1 2 0 1 0 5 55 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 221 K E e 27.4 8d82_F antibody heavy chain[220 aa]:antibody heavy chain[227 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. IL6RA_HUMAN:Interleukin-6 receptor subunit alpha[14 aa] CO3:GOL 5 0 1 3 0 4 3 6 23 4 0 0 11 12 9 5 5 3 0 4 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 222 P b 3.1 8d82_F antibody heavy chain[227 aa] NGA GOL 4 0 2 0 0 0 0 0 0 7 0 0 72 1 0 5 6 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 223 N e 46.7 8d82_F antibody light chain[215 aa]:antibody heavy chain[220 aa]:antibody light chain[216 aa]:antibody heavy chain[227 aa] NGA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. IL6RA_HUMAN:Interleukin-6 receptor subunit alpha[14 aa] GOL:SO4 5 0 19 12 0 16 5 2 7 12 4 8 0 2 3 6 1 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 224 P e 23.3 8d82_F antibody light chain[215 aa]:antibody heavy chain[220 aa]:antibody light chain[216 aa]:antibody heavy chain[227 aa] GOL:SO4 15 0 1 0 0 0 0 1 2 0 2 1 66 2 0 3 2 3 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 225 P b 0.0 8d82_F 0 0 0 2 1 0 0 2 0 0 0 0 90 0 0 3 1 0 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 226 H E e 42.9 8d82_F antibody light chain[215 aa]:antibody light chain[216 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL:SO4 9 0 0 10 7 5 4 7 1 2 5 0 3 7 9 8 8 6 3 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 227 N E e 73.3 8d82_F anti-IL-7R 2B8 Fab light chain[213 aa] NAG:FUC 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 6 0 17 1 0 8 2 4 2 5 0 30 5 2 5 9 1 2 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 228 L E b 12.9 8d82_F anti-IL-7R 2B8 Fab light chain[213 aa] 3 0 0 0 4 1 0 14 0 40 2 0 6 2 4 2 0 20 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 229 S E e 47.7 8d82_F anti-IL-7R 2B8 Fab light chain[213 aa] NAG 4 0 4 7 0 9 3 0 14 1 0 2 0 3 10 16 15 11 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 230 V E e 22.7 8d82_F Anti-IL-7R 2B8 Fab heavy chain[223 aa] 14 0 0 0 4 0 0 10 0 11 2 2 0 2 0 1 2 49 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 231 I E e 40.9 8d82_F Anti-IL-7R 2B8 Fab heavy chain[223 aa]:anti-IL-7R 2B8 Fab light chain[213 aa] PRLR_RAT:IL6A_HUMAN:PROLACTIN RECEPTOR[195 aa]:IL-6 Receptor alpha chain[299 aa]:Prolactin receptor[202 aa] 1 0 5 11 2 1 2 16 14 8 2 2 1 2 2 7 9 14 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 232 N e 40.6 8d82_F Anti-IL-7R 2B8 Fab heavy chain[223 aa] IL6A_HUMAN:CRLF1_HUMAN:IL-6 Receptor alpha chain[299 aa]:Cytokine receptor-like factor 1[303 aa] SO4 12 1 9 2 7 4 5 7 6 2 1 13 6 2 5 8 4 1 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 233 S b 19.5 8d82_F IL6RA_HUMAN:IL4RA_HUMAN:CRLF2_HUMAN:CNTFR_HUMAN:I11RA_HUMAN:Interleukin-6 receptor alpha chain[201 aa]:Interleukin-4 receptor subunit alpha[183 aa]:Cytokine receptor-like factor 2[190 aa]:anti-IL-7R 2B8 Fab light chain[213 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[197 aa] IL6A_HUMAN:IL-6 Receptor alpha chain[299 aa] GOL 9 0 5 7 0 2 0 8 6 3 0 3 6 2 7 11 10 17 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 234 E S e 48.2 8d82_F IL6RA_HUMAN:IL4RA_HUMAN:CNTFR_HUMAN:I11RA_HUMAN:Interleukin-6 receptor alpha chain[201 aa]:Interleukin-4 receptor subunit alpha[183 aa]:anti-IL-7R 2B8 Fab light chain[213 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa] alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. IL6A_HUMAN:IL-6 Receptor alpha chain[299 aa] 5 0 6 35 0 6 2 1 3 3 0 10 11 0 3 5 6 4 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 235 E S e 81.9 8d82_F CRLF2_HUMAN:CNTFR_HUMAN:IL6RA_HUMAN:I11RA_HUMAN:Cytokine receptor-like factor 2[190 aa]:anti-IL-7R 2B8 Fab light chain[213 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6 receptor subunit alpha[201 aa] IL6A_HUMAN:IL-6 Receptor alpha chain[299 aa] 8 0 11 14 1 12 1 6 3 1 0 3 2 4 6 12 5 10 1 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 236 L S e 61.2 8d82_F CRLF2_HUMAN:CNTFR_HUMAN:IL6RA_HUMAN:I11RA_HUMAN:Cytokine receptor-like factor 2[190 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6 receptor subunit alpha[201 aa] IL6A_HUMAN:IL-6 Receptor alpha chain[299 aa] 12 2 2 1 0 2 1 11 5 12 2 8 2 1 11 7 14 2 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 237 S S e 32.0 8d82_F alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. PRLR_RAT:PROLACTIN RECEPTOR[169 aa]:Prolactin receptor[199 aa] 8 0 6 3 0 4 0 0 9 1 0 10 11 2 1 24 12 4 1 1 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 238 S S e 22.7 8d82_F IL6RB_HUMAN:CRLF2_HUMAN:CNTFR_HUMAN:IL6RB_MOUSE:Interleukin-6 receptor beta chain[298 aa]:Cytokine receptor-like factor 2[190 aa]:Interleukin-6 receptor subunit beta[392 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be..:alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] 9 0 5 1 0 4 0 1 3 4 0 2 5 3 17 20 22 1 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 239 I b 10.5 8d82_F IL6RB_HUMAN:CNTFR_HUMAN:IL6RA_HUMAN:I11RA_HUMAN:IL6RB_MOUSE:Interleukin-6 receptor beta chain[298 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[589 aa]:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6 receptor subunit alpha[201 aa]:Interleukin-6 receptor subunit beta[584 aa] IL6A_HUMAN:IL-6 Receptor alpha chain[299 aa] GOL 6 6 0 3 5 1 0 10 2 5 3 0 0 3 7 13 14 10 4 8 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 240 L E b 0.0 8d82_F 7 2 0 0 3 1 0 19 0 34 0 0 2 0 0 0 2 27 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 241 K E e 26.4 8d82_F IL6RA_HUMAN:NET1_HUMAN:CNTFR_HUMAN:I11RA_HUMAN:Interleukin-6 receptor alpha chain[201 aa]:NETRIN-1[420 aa]:VHH6[110 aa]:anti-IL-7R 2B8 Fab light chain[213 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa]:Interleukin-6 receptor subunit alpha[201 aa] NAG PRLR_RAT:PROLACTIN RECEPTOR[195 aa]:Prolactin receptor[203 aa]:Prolactin receptor[202 aa] SO4 4 0 0 5 0 1 3 0 15 3 2 3 0 12 10 6 19 3 7 4 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 242 L E b 0.0 8d82_F 3 0 0 0 3 0 0 11 0 49 4 0 0 0 0 0 0 26 2 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 243 T E e 29.2 8d82_F VHH6[110 aa]:VHH6[124 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4 3 1 2 4 0 0 2 2 6 2 0 2 0 6 7 37 20 2 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 244 W E b 2.0 8d82_F VHH6[110 aa]:VHH6[124 aa] 0 0 0 0 1 0 0 0 0 0 0 0 2 0 0 0 2 0 95 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 245 T E e 43.5 8d82_F NET1_HUMAN:NETRIN-1[420 aa]:VHH6[110 aa]:VHH6[124 aa] NAG:NGA SO4:GOL 7 0 8 12 1 0 2 2 13 1 0 1 0 15 6 12 12 4 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 246 N b 12.7 8d82_F VHH6[110 aa]:VHH6[124 aa] NAG SO4:GOL 6 0 7 7 0 0 3 0 9 5 2 5 30 2 3 7 5 5 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 247 P b 0.8 8d82_F NET1_HUMAN:NETRIN-1[420 aa] NGA:NAG GOL:SO4 3 0 0 4 0 11 3 2 2 2 0 1 63 0 3 3 0 0 1 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 248 S G e 75.8 8d82_F Q98823_HHV8:VIRAL IL-6[167 aa]:antibody heavy chain[220 aa] NAG:NGA 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a..:beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. GOL:SO4 7 0 7 13 2 9 4 0 0 3 0 2 4 6 4 19 12 5 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 249 I G b 5.3 8d82_F CSF3_HUMAN:PRL_HUMAN:LEP_HUMAN:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:Prolactin[185 aa]:antibody heavy chain[220 aa]:antibody heavy chain[227 aa]:Leptin[94 aa] NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. IL6RA_HUMAN:Interleukin-6 receptor subunit alpha[14 aa] 4 1 15 3 6 3 3 4 5 13 5 5 6 9 3 7 3 1 4 1 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 250 K G e 43.9 8d82_F CSF3_HUMAN:IL7_HUMAN:PRL_HUMAN:TSLP_HUMAN:CLCF1_HUMAN:IL6_HUMAN:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:Interleukin-7[115 aa]:Interleukin-7[110 aa]:Interleukin-7[118 aa]:Prolactin[186 aa]:Thymic stromal lymphopoietin[114 aa]:IL7R binder[55 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[157 aa] 2-acetamido-2-deoxy-alpha-D-glucopyranose-(1-4)-al.. IL6RB_HUMAN:IL7RA_HUMAN:PROTEIN (GP130)[215 aa]:Interleukin-7 receptor subunit alpha[196 aa]:Interleukin-7 receptor subunit alpha[201 aa] SO4 4 2 2 9 5 10 0 2 7 0 1 11 19 3 6 7 9 1 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 251 S G e 81.2 8d82_F SOMA_HUMAN:CSH_SHEEP:Q98823_HHV8:IL6_HUMAN:IL4_HUMAN:PRL_HUMAN:IL7_HUMAN:IL13_HUMAN:TSLP_HUMAN:LEP_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PLACENTAL LACTOGEN[183 aa]:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Interleukin-4[126 aa]:Prolactin[165 aa]:Interleukin-7[115 aa]:Interleukin-7[110 aa]:Interleukin-7[118 aa]:Prolactin[185 aa]:Prolactin[186 aa]:Interleukin-13[111 aa]:INTERLEUKIN-6[160 aa]:VHH6[110 aa]:INTERLEUKIN-6[152 aa]:VHH6[124 aa]:Thymic stromal lymphopoietin[114 aa]:Switch Ab Fab light chain[212 aa]:IL7R binder[55 aa]:Leptin[94 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa] NGA IL6RB_HUMAN:IL7RA_HUMAN:PROTEIN (GP130)[215 aa]:Interleukin-7 receptor subunit alpha[196 aa]:Interleukin-7 receptor subunit alpha[201 aa] 4 0 11 6 0 6 6 2 2 2 0 25 7 4 4 11 6 0 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 252 V T e 34.7 8d82_F SOMA_HUMAN:CSH_SHEEP:Q98823_HHV8:IL6_HUMAN:LIF_HUMAN:CSF3_HUMAN:PRL_HUMAN:LEP_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PLACENTAL LACTOGEN[183 aa]:VIRAL IL-6[167 aa]:Interleukin-6[163 aa]:Leukemia inhibitory factor[169 aa]:CSF3[168 aa]:Prolactin[186 aa]:INTERLEUKIN-6[160 aa]:INTERLEUKIN-6[152 aa]:VHH6[124 aa]:Switch Ab Fab light chain[212 aa]:Leptin[94 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Heavy chain of Sarilumab Fab[207 aa]:Interleukin-6[157 aa] NAG IL6RB_HUMAN:IL7RA_HUMAN:PROTEIN (GP130)[215 aa]:Interleukin-7 receptor subunit alpha[201 aa] 0 0 3 5 2 21 6 5 5 2 0 2 0 2 4 18 3 17 0 4 MUTAGEN:/note="V->G: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":MUTAGEN:/note="V->G: Induces ligand-independent activation.":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 253 I S b 7.0 8d82_F SOMA_HUMAN:CSH_SHEEP:IL6_HUMAN:CSF3_HUMAN:IL4_HUMAN:IL13_HUMAN:LEP_MOUSE:LEP_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PLACENTAL LACTOGEN[183 aa]:Interleukin-6[163 aa]:CSF3[168 aa]:Interleukin-4[126 aa]:Interleukin-13[111 aa]:INTERLEUKIN-6[160 aa]:INTERLEUKIN-6[152 aa]:Switch Ab Fab heavy chain[209 aa]:IL7R binder[55 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Leptin[138 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Heavy chain of Sarilumab Fab[207 aa]:Interleukin-6[157 aa] NAG PRLR_RAT:IL6RA_HUMAN:Prolactin receptor[202 aa]:Interleukin-6 receptor subunit alpha[14 aa] GOL 5 3 5 5 10 0 0 16 9 8 3 4 14 0 2 3 1 8 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 254 I e 53.2 8d82_F SOMA_HUMAN:CSH_SHEEP:IL6RA_HUMAN:IL6_HUMAN:CSF3_HUMAN:IL4_HUMAN:PRL_HUMAN:IL13_HUMAN:LEP_HUMAN:LEP_MOUSE:CNTF_HUMAN:CLCF1_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PLACENTAL LACTOGEN[183 aa]:Interleukin-6 receptor alpha chain[201 aa]:Interleukin-6[163 aa]:CSF3[168 aa]:Interleukin-4[126 aa]:Prolactin[186 aa]:Interleukin-13[111 aa]:INTERLEUKIN-6[160 aa]:VHH6[110 aa]:INTERLEUKIN-6[152 aa]:VHH6[124 aa]:Switch Ab Fab light chain[212 aa]:Switch Ab Fab heavy chain[209 aa]:Leptin[100 aa]:Leptin[102 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Leptin[138 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Soluble interleukin-6 receptor subunit alpha[296 a..:Heavy chain of Sarilumab Fab[207 aa]:Interleukin-6 receptor subunit alpha[201 aa]:Interleukin-6[157 aa] NGA IL6RB_HUMAN:PRLR_RAT:PROTEIN (GP130)[215 aa]:Prolactin receptor[199 aa] 0 2 1 2 7 3 0 31 3 9 1 6 5 0 2 2 6 19 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 255 L E b 0.0 8d82_F LEP_MOUSE:LEP_HUMAN:Leptin[140 aa]:Leptin[146 aa]:Leptin[141 aa] NGA 1 5 2 0 3 0 0 8 2 45 1 0 3 5 4 4 10 4 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 256 K E e 22.2 8d82_F CSH_SHEEP:PRL_HUMAN:IL4RA_HUMAN:LEP_HUMAN:LEP_MOUSE:PLACENTAL LACTOGEN[183 aa]:Prolactin[185 aa]:Prolactin[186 aa]:Interleukin-4 receptor subunit alpha[183 aa]:anti-IL-7R 2B8 Fab light chain[213 aa]:Switch Ab Fab heavy chain[209 aa]:Leptin[100 aa]:Leptin[102 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Leptin[138 aa]:Light chain of Sarilumab Fab[212 aa]:Heavy chain of Sarilumab Fab[207 aa] IL6RB_HUMAN:PROTEIN (GP130)[208 aa] 5 0 3 8 2 11 0 5 18 7 5 3 0 10 5 8 4 2 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 257 Y E b 0.0 8d82_F LEP_HUMAN:LEP_MOUSE:Leptin[100 aa]:Leptin[102 aa]:Leptin[141 aa]:Leptin[140 aa]:Leptin[146 aa]:Leptin[138 aa]:Light chain of Sarilumab Fab[212 aa] 2 12 0 0 13 0 3 0 2 2 0 5 0 0 0 2 0 3 0 56 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 258 N b 7.3 8d82_F IL6RB_HUMAN:A0A161FW14_MESMA:PROTEIN (GP130)[208 aa]:Dscam[288 aa]:Dscam[275 aa] 2 0 7 22 3 2 0 7 4 3 1 7 0 17 10 5 8 2 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 259 I b 0.0 8d82_F 0 0 0 0 3 0 0 40 0 34 3 0 1 0 0 2 0 16 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 260 Q E b 11.2 8d82_F A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] IMD 5 0 0 19 2 2 4 1 7 2 0 1 0 23 30 2 2 0 1 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 261 Y E e 24.3 8d82_F IL6RB_HUMAN:NET1_HUMAN:IL6RB_MOUSE:Interleukin-6 receptor beta chain[298 aa]:NETRIN-1[420 aa]:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] IMD 4 3 0 0 11 0 5 3 4 11 2 0 0 0 3 3 1 5 1 44 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 262 R E b 17.4 8d82_F A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] IMD 0 3 2 5 0 1 2 0 23 2 1 5 0 6 40 4 0 2 0 4 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 263 T e 22.1 8d82_F 7 0 0 10 0 5 0 3 3 10 3 5 20 2 4 5 17 5 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 264 K S e 54.2 8d82_F CRLF1_HUMAN:Cytokine receptor-like factor 1[303 aa] 14 3 0 13 1 2 2 4 21 4 0 6 5 2 6 7 4 3 1 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 265 D S e 87.0 8d82_F CSF3_HUMAN:IL6RB_HUMAN:IL6RB_MOUSE:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:Interleukin-6 receptor beta chain[298 aa]:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] A0A161FW14_MESMA:Dscam[275 aa] 1 0 19 8 6 11 0 2 2 2 0 10 0 9 6 9 7 0 0 6 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 266 A e 27.7 8d82_F CSF3_HUMAN:IL6RB_HUMAN:IL4RA_HUMAN:IL6RB_MOUSE:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:Interleukin-6 receptor beta chain[298 aa]:Interleukin-4 receptor alpha chain[199 aa]:Anti-IL-7R 2B8 Fab heavy chain[223 aa]:Anti-IL-7R 2B8 Fab heavy chain[220 aa]:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] NAG A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] 15 0 4 10 3 10 5 0 5 6 0 5 0 1 2 21 7 1 3 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 267 S e 72.7 8d82_F IL6RB_HUMAN:IL6RB_MOUSE:Interleukin-6 receptor beta chain[298 aa]:Anti-IL-7R 2B8 Fab heavy chain[223 aa]:anti-IL-7R 2B8 Fab light chain[213 aa]:Anti-IL-7R 2B8 Fab heavy chain[220 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] A0A161FW14_MESMA:Dscam[275 aa] 7 0 4 15 0 9 0 2 4 5 3 3 5 5 6 13 12 6 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 268 T S e 68.8 8d82_F CSF3_HUMAN:IL6RB_HUMAN:IL4RA_HUMAN:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:Interleukin-6 receptor beta chain[298 aa]:Interleukin-4 receptor alpha chain[199 aa]:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-6 receptor subunit beta[398 aa] NAG PRLR_RAT:A0A161FW14_MESMA:PROLACTIN RECEPTOR[169 aa]:Prolactin receptor[199 aa]:Dscam[288 aa]:Dscam[275 aa] 8 0 5 9 0 8 3 3 4 7 3 5 4 2 2 11 19 5 2 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 269 W e 33.9 8d82_F CSF3_HUMAN:IL6RB_HUMAN:IL6RB_MOUSE:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:anti-IL-7R 2B8 Fab light chain[213 aa]:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[584 aa] A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] SO4 3 0 3 4 2 1 4 1 3 2 2 2 2 4 4 1 2 5 52 6 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 270 S E e 44.5 8d82_F CSF3_HUMAN:IL6RB_HUMAN:IL4RA_HUMAN:IL6RB_MOUSE:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:Interleukin-6 receptor beta chain[298 aa]:Interleukin-4 receptor subunit alpha[183 aa]:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] NAG PRLR_RAT:A0A161FW14_MESMA:PROLACTIN RECEPTOR[169 aa]:Prolactin receptor[181 aa]:Prolactin receptor[199 aa]:Dscam[288 aa]:Dscam[275 aa] SO4 7 0 0 14 4 5 5 3 6 1 5 9 1 9 4 15 8 2 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 271 Q E e 42.9 8d82_F CSF3_HUMAN:IL6RB_HUMAN:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:anti-IL-7R 2B8 Fab light chain[213 aa]:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa] IL6RB_HUMAN:PRLR_RAT:A0A161FW14_MESMA:PROTEIN (GP130)[208 aa]:PROLACTIN RECEPTOR[169 aa]:Prolactin receptor[181 aa]:Prolactin receptor[199 aa]:Dscam[288 aa]:Dscam[275 aa] SO4 8 0 4 15 2 4 8 3 6 5 6 6 1 8 6 1 14 3 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 272 I b 7.6 8d82_F CSF3_HUMAN:IL4RA_HUMAN:IL6RB_HUMAN:IL6RB_MOUSE:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:Interleukin-4 receptor alpha chain[199 aa]:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] 3 0 1 1 4 3 2 8 1 13 2 3 1 3 3 2 4 40 1 5 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 273 P e 62.8 8d82_F IL4RA_HUMAN:NET1_HUMAN:IL6RB_MOUSE:Interleukin-4 receptor alpha chain[199 aa]:NETRIN-1[420 aa]:Light chain of Sarilumab Fab[212 aa]:Interleukin-6 receptor subunit beta[584 aa] IL6RB_HUMAN:A0A161FW14_MESMA:PROTEIN (GP130)[208 aa]:Dscam[275 aa] 5 1 6 14 1 4 1 7 8 5 2 7 12 2 5 8 9 2 1 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 274 P G e 54.3 8d82_F Heavy chain of Sarilumab Fab[207 aa] IL6RB_HUMAN:A0A161FW14_MESMA:PROTEIN (GP130)[208 aa]:Dscam[288 aa]:Dscam[275 aa] 5 1 1 9 2 7 4 4 2 6 2 1 19 3 3 4 10 13 0 4 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 275 E G e 76.9 8d82_F IL6RB_HUMAN:IL4RA_HUMAN:IL6RA_HUMAN:I11RA_HUMAN:IL6RB_MOUSE:Interleukin-6 receptor beta chain[298 aa]:Interleukin-4 receptor alpha chain[199 aa]:Interleukin-6 receptor subunit beta[589 aa]:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa]:Heavy chain of Sarilumab Fab[207 aa]:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6 receptor subunit alpha[201 aa]:Interleukin-6 receptor subunit beta[584 aa] IL6RB_HUMAN:PROTEIN (GP130)[208 aa] 5 0 4 31 5 2 2 3 8 7 0 4 1 5 4 6 5 5 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 276 D G e 50.6 8d82_F IL6RA_HUMAN:IL4RA_HUMAN:CNTFR_HUMAN:I11RA_HUMAN:Interleukin-6 receptor alpha chain[201 aa]:Interleukin-4 receptor alpha chain[199 aa]:Switch Ab Fab light chain[212 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa]:Heavy chain of Sarilumab Fab[207 aa]:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6 receptor subunit alpha[201 aa] PRLR_RAT:PROLACTIN RECEPTOR[169 aa]:Prolactin receptor[181 aa]:Prolactin receptor[199 aa]:Prolactin receptor[202 aa] 2 0 23 3 4 9 7 5 2 6 0 11 3 3 4 9 2 5 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 277 T G b 0.6 8d82_F IL6_HUMAN:INTERLEUKIN-6[160 aa]:INTERLEUKIN-6[152 aa]:Switch Ab Fab light chain[212 aa]:Heavy chain of Sarilumab Fab[207 aa] PRLR_RAT:PROLACTIN RECEPTOR[195 aa]:Prolactin receptor[203 aa]:Prolactin receptor[199 aa]:Prolactin receptor[202 aa] SO4 10 3 1 1 6 4 0 6 4 11 0 5 3 0 1 4 26 13 0 1 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 278 A e 25.9 8d82_F NAG 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. IL6RB_HUMAN:PRLR_RAT:PROTEIN (GP130)[208 aa]:PROLACTIN RECEPTOR[195 aa]:Prolactin receptor[203 aa] SO4 11 0 5 10 2 3 0 2 6 5 1 4 4 0 2 12 11 18 0 4 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 279 S S e 53.9 8d82_F IL6RA_HUMAN:Interleukin-6 receptor alpha chain[201 aa]:Interleukin-6 receptor subunit alpha[201 aa] PRLR_RAT:PROLACTIN RECEPTOR[195 aa]:Prolactin receptor[203 aa]:Prolactin receptor[202 aa] SO4 6 0 8 6 2 15 1 4 5 1 3 5 6 2 2 22 6 5 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 280 T e 38.3 8d82_F SOMA_HUMAN:CSH_SHEEP:CNTF_HUMAN:I11RA_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PLACENTAL LACTOGEN[183 aa]:Ciliary neurotrophic factor[174 aa]:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa] NAG PRLR_RAT:PROLACTIN RECEPTOR[195 aa]:Prolactin receptor[203 aa]:Prolactin receptor[199 aa]:Prolactin receptor[202 aa] 6 0 3 2 0 2 5 0 12 4 0 5 7 9 1 12 23 6 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 281 R e 34.8 8d82_F CSF3_HUMAN:IL6RA_HUMAN:CRLF2_HUMAN:CNTFR_HUMAN:I11RA_HUMAN:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:Interleukin-6 receptor alpha chain[201 aa]:VHH6[110 aa]:VHH6[124 aa]:Cytokine receptor-like factor 2[190 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa]:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6 receptor subunit alpha[201 aa] NAG PRLR_RAT:PROLACTIN RECEPTOR[195 aa]:Prolactin receptor[203 aa]:Prolactin receptor[202 aa] SO4:GOL 5 0 2 6 0 4 2 1 13 6 3 4 1 16 12 8 15 1 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 282 S S e 35.9 8d82_F CNTFR_HUMAN:I11RA_HUMAN:VHH6[110 aa]:VHH6[124 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa] SO4 6 1 2 5 3 5 3 1 2 4 3 7 7 5 6 6 24 4 0 6 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 283 S E e 44.5 8d82_F IL6RA_HUMAN:CRLF2_HUMAN:CNTFR_HUMAN:I11RA_HUMAN:Interleukin-6 receptor alpha chain[201 aa]:VHH6[110 aa]:VHH6[124 aa]:Cytokine receptor-like factor 2[190 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa]:Interleukin-11 receptor subunit alpha[197 aa] PRLR_RAT:DCC_HUMAN:PROLACTIN RECEPTOR[195 aa]:Prolactin receptor[203 aa]:Prolactin receptor[202 aa]:Netrin receptor DCC[202 aa] SO4 4 2 2 8 1 1 6 1 2 3 1 5 4 16 8 22 9 3 2 1 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 284 F E b 13.4 8d82_F IL6RA_HUMAN:IL4RA_HUMAN:CNTFR_HUMAN:I11RA_HUMAN:Interleukin-6 receptor alpha chain[201 aa]:Interleukin-4 receptor alpha chain[199 aa]:Interleukin-4 receptor subunit alpha[183 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa]:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6 receptor subunit alpha[201 aa] PRLR_RAT:PROLACTIN RECEPTOR[169 aa]:PROLACTIN RECEPTOR[195 aa]:Prolactin receptor[181 aa]:Prolactin receptor[203 aa]:Prolactin receptor[199 aa]:Prolactin receptor[202 aa] SO4 14 6 1 1 18 1 7 4 1 9 0 1 1 2 1 1 2 12 0 21 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 285 T E e 31.2 8d82_F IL6RA_HUMAN:NET1_HUMAN:CRLF2_HUMAN:CNTFR_HUMAN:I11RA_HUMAN:Interleukin-6 receptor alpha chain[201 aa]:NETRIN-1[420 aa]:Cytokine receptor-like factor 2[190 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-11 receptor subunit alpha[283 aa]:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6 receptor subunit alpha[201 aa] NAG PRLR_RAT:PROLACTIN RECEPTOR[169 aa]:PROLACTIN RECEPTOR[195 aa]:Prolactin receptor[181 aa]:Prolactin receptor[203 aa]:Prolactin receptor[199 aa]:Prolactin receptor[202 aa] SO4 7 0 3 6 2 0 0 4 5 12 5 3 4 4 2 7 24 8 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 286 V E b 4.7 8d82_F PRLR_RAT:PROLACTIN RECEPTOR[169 aa]:Prolactin receptor[181 aa]:Prolactin receptor[199 aa] 8 0 1 2 4 0 0 28 0 16 4 0 0 3 0 0 0 32 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 287 Q e 49.0 8d82_F IL6RA_HUMAN:IL6RB_HUMAN:IL4RA_HUMAN:NET1_HUMAN:CRLF2_HUMAN:CNTFR_HUMAN:I11RA_HUMAN:IL6RB_MOUSE:Interleukin-6 receptor alpha chain[201 aa]:Interleukin-6 receptor beta chain[298 aa]:Interleukin-4 receptor alpha chain[199 aa]:NETRIN-1[420 aa]:Interleukin-4 receptor subunit alpha[183 aa]:Cytokine receptor-like factor 2[190 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[589 aa]:Soluble interleukin-6 receptor subunit alpha[296 a..:Interleukin-11 receptor subunit alpha[200 aa]:Interleukin-11 receptor subunit alpha[294 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-11 receptor subunit alpha[283 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-11 receptor subunit alpha[197 aa]:Interleukin-6 receptor subunit alpha[201 aa]:Interleukin-6 receptor subunit beta[584 aa] alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. PRLR_RAT:PROLACTIN RECEPTOR[169 aa]:PROLACTIN RECEPTOR[195 aa]:Prolactin receptor[181 aa]:Prolactin receptor[203 aa]:Prolactin receptor[199 aa]:Prolactin receptor[202 aa] EDO 2 3 8 3 7 6 4 4 2 5 0 1 6 10 4 10 17 7 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 288 D S e 95.1 8d82_F IL6RB_HUMAN:IL4RA_HUMAN:NET1_HUMAN:CRLF2_HUMAN:CNTFR_HUMAN:IL6RB_MOUSE:Interleukin-6 receptor beta chain[298 aa]:Interleukin-4 receptor alpha chain[199 aa]:NETRIN-1[420 aa]:Interleukin-4 receptor subunit alpha[183 aa]:Cytokine receptor-like factor 2[190 aa]:Ciliary neurotrophic factor receptor subunit alpha..:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] PRLR_RAT:A0A161FW14_MESMA:PROLACTIN RECEPTOR[169 aa]:PROLACTIN RECEPTOR[195 aa]:Prolactin receptor[181 aa]:Prolactin receptor[203 aa]:Prolactin receptor[199 aa]:Prolactin receptor[202 aa]:Dscam[288 aa]:Dscam[275 aa] EDO:SO4 0 0 37 5 0 25 0 0 10 0 0 12 0 0 0 6 0 0 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 289 L b 10.7 8d82_F NET1_HUMAN:IL6RB_HUMAN:IL6RB_MOUSE:NETRIN-1[420 aa]:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] PRLR_RAT:A0A161FW14_MESMA:Prolactin receptor[181 aa]:Dscam[288 aa]:Dscam[275 aa] EDO 8 0 0 0 1 0 0 1 0 86 0 0 0 0 0 0 0 3 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 290 K e 57.5 8d82_F IL6RB_HUMAN:IL4RA_HUMAN:NET1_HUMAN:IL6RB_MOUSE:Interleukin-6 receptor beta chain[298 aa]:Interleukin-4 receptor alpha chain[199 aa]:NETRIN-1[420 aa]:Interleukin-6 receptor subunit beta[392 aa]:Interleukin-6 receptor subunit beta[589 aa]:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] PRLR_RAT:A0A161FW14_MESMA:PROLACTIN RECEPTOR[169 aa]:Prolactin receptor[181 aa]:Prolactin receptor[199 aa]:Dscam[288 aa]:Dscam[275 aa] SO4:EDO 3 0 3 15 0 0 4 1 15 7 2 10 0 12 7 9 2 3 2 5 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 291 P S e 35.7 8d82_F IL6RB_HUMAN:IL6RB_MOUSE:Interleukin-6 receptor subunit beta[398 aa]:Interleukin-6 receptor subunit beta[298 aa]:Interleukin-6 receptor subunit beta[584 aa] A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] 7 0 0 2 0 0 0 0 4 2 0 0 76 2 2 3 0 0 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 292 F S e 33.0 8d82_F CYS EDO 13 4 9 6 17 22 0 0 2 1 0 6 0 0 0 2 0 0 6 11 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 293 T b 19.5 8d82_F IL6RB_HUMAN:Interleukin-6 receptor subunit beta[392 aa] EDO 8 0 0 2 0 1 0 2 7 4 2 0 1 3 1 12 48 9 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 294 E E e 30.7 8d82_F Anti-IL-7R 2B8 Fab heavy chain[223 aa] IL6A_HUMAN:CRLF1_HUMAN:IL-6 Receptor alpha chain[299 aa]:Cytokine receptor-like factor 1[303 aa] 5 1 2 24 0 2 0 2 15 4 3 5 3 1 5 6 9 11 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 295 Y E b 7.8 8d82_F PRLR_RAT:Prolactin receptor[181 aa] SO4 0 0 0 0 0 0 6 0 0 0 0 2 0 0 0 0 0 0 0 92 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 296 V E b 2.7 8d82_F IMD 10 1 0 18 3 0 2 9 6 7 1 1 0 1 0 7 12 19 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 297 F E b 0.0 8d82_F 4 0 0 0 51 0 0 11 0 4 0 0 0 0 0 0 0 25 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 298 R E b 16.2 8d82_F NA A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] SO4:IMD 6 1 0 0 1 0 2 0 7 0 0 2 0 29 41 3 2 0 0 6 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 299 I b 0.0 8d82_F 0 0 0 0 0 3 0 23 0 10 8 0 0 0 0 0 2 54 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 300 R e 24.1 8d82_F anti-IL-7R 2B8 Fab light chain[213 aa] IL6RB_HUMAN:PROTEIN (GP130)[208 aa] SO4 4 0 0 0 0 0 2 1 0 2 7 0 0 4 52 13 4 7 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 301 C E b 0.0 8d82_F IL4_HUMAN:IL13_HUMAN:Interleukin-4[126 aa]:Interleukin-13[111 aa] 43 32 0 0 1 2 0 2 0 0 0 0 2 0 0 12 1 5 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 302 M E b 3.4 8d82_F IL4_HUMAN:IL13_HUMAN:CLCF1_HUMAN:IL11_HUMAN:Interleukin-4[126 aa]:Interleukin-13[111 aa]:anti-IL-7R 2B8 Fab light chain[213 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa] SO4 8 3 0 2 1 2 2 8 16 2 4 0 0 8 13 7 4 9 1 9 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 303 K E b 11.3 8d82_F CSF3_HUMAN:IL6_HUMAN:IL4_HUMAN:IL13_HUMAN:LEP_HUMAN:IL11_HUMAN:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:Interleukin-6[163 aa]:CSF3[168 aa]:Interleukin-4[126 aa]:Interleukin-13[111 aa]:INTERLEUKIN-6[160 aa]:INTERLEUKIN-6[152 aa]:Switch Ab Fab heavy chain[209 aa]:Leptin[146 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Heavy chain of Sarilumab Fab[207 aa] IL6RB_HUMAN:PROTEIN (GP130)[215 aa] 2 0 4 6 1 3 0 0 7 2 3 25 8 4 7 6 18 2 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 304 E T e 37.7 8d82_F SOMA_HUMAN:CSH_SHEEP:IL6_HUMAN:PRL_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:PLACENTAL LACTOGEN[183 aa]:Interleukin-6[163 aa]:Prolactin[165 aa]:Prolactin[185 aa]:Prolactin[186 aa]:INTERLEUKIN-6[160 aa]:INTERLEUKIN-6[152 aa]:Switch Ab Fab heavy chain[209 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Heavy chain of Sarilumab Fab[207 aa]:Interleukin-6[157 aa] ZN 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. IL6RB_HUMAN:PROTEIN (GP130)[215 aa] 11 0 10 18 2 3 4 3 4 3 0 6 5 2 7 15 1 3 1 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 305 D T e 48.8 8d82_F CSF3_HUMAN:CSH_SHEEP:IL6_HUMAN:PRL_HUMAN:LEP_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:PLACENTAL LACTOGEN[183 aa]:Interleukin-6[163 aa]:Prolactin[185 aa]:Prolactin[186 aa]:INTERLEUKIN-6[160 aa]:INTERLEUKIN-6[152 aa]:Switch Ab Fab heavy chain[209 aa]:IL7R binder[55 aa]:Leptin[146 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Light chain of Sarilumab Fab[212 aa]:Heavy chain of Sarilumab Fab[207 aa]:Interleukin-6[157 aa] ATP 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. IL6RB_HUMAN:PROTEIN (GP130)[208 aa] 7 0 14 1 3 2 4 13 6 9 1 9 3 4 1 6 8 5 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 306 G S e 57.1 8d82_F CSF3_HUMAN:IL7_HUMAN:PRL_HUMAN:TSLP_HUMAN:CNTF_HUMAN:CLCF1_HUMAN:IL11_HUMAN:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[17..:PROTEIN (GRANULOCYTE COLONY-STIMULATING FACTOR)[16..:CSF3[168 aa]:Interleukin-7[118 aa]:Prolactin[186 aa]:Thymic stromal lymphopoietin[114 aa]:Ciliary neurotrophic factor[174 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-11[165 aa]:Interleukin-11[164 aa]:Light chain of Sarilumab Fab[212 aa]:Heavy chain of Sarilumab Fab[207 aa] IL7RA_HUMAN:Interleukin-7 receptor subunit alpha[196 aa]:Interleukin-7 receptor subunit alpha[201 aa] 2 0 5 3 6 57 6 2 1 3 2 0 0 1 2 5 0 1 0 2 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 307 K S e 52.8 8d82_F SOMA_HUMAN:IL6_HUMAN:PRL_HUMAN:LEP_HUMAN:CLCF1_HUMAN:PROTEIN (GROWTH HORMONE)[186 aa]:Interleukin-6[163 aa]:Prolactin[165 aa]:Prolactin[186 aa]:INTERLEUKIN-6[160 aa]:INTERLEUKIN-6[152 aa]:anti-IL-7R 2B8 Fab light chain[213 aa]:Switch Ab Fab heavy chain[209 aa]:IL7R binder[55 aa]:Leptin[146 aa]:Cardiotrophin-like cytokine factor 1[178 aa]:Interleukin-6[169 aa]:Interleukin-6[157 aa] ZN IL6RB_HUMAN:PROTEIN (GP130)[208 aa] 6 3 3 5 4 3 8 7 20 8 1 4 3 2 7 3 4 3 0 6 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 308 G S b 14.3 8d82_F EDO 1 0 3 1 1 64 0 1 3 2 0 1 1 1 4 5 3 1 7 1 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 309 Y e 34.8 8d82_F anti-IL-7R 2B8 Fab light chain[213 aa] CL 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. GOL:CO3:EDO:SO4:PGE:PEG 4 1 2 8 12 4 2 2 9 9 1 4 7 4 3 6 7 4 0 11 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 310 W e 30.3 8d82_F anti-IL-7R 2B8 Fab light chain[213 aa]:Light chain of Sarilumab Fab[212 aa] IOD:CL IL6RB_HUMAN:PROTEIN (GP130)[208 aa] SO4:CO3 2 1 3 3 7 2 1 1 2 3 1 1 9 1 1 4 2 2 51 4 MOTIF:/note="WSXWS motif":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":MOTIF:/note="WSXWS motif":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 311 S b 4.7 8d82_F GOL 1 3 1 3 1 7 0 1 1 1 0 1 4 4 1 68 3 1 0 0 MOTIF:/note="WSXWS motif":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":MOTIF:/note="WSXWS motif":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 312 D e 60.5 8d82_F NET1_HUMAN:NETRIN-1[420 aa] NAG SO4:GOL 4 0 17 28 0 1 0 0 8 2 0 7 11 5 4 4 6 1 0 0 MOTIF:/note="WSXWS motif":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":MOTIF:/note="WSXWS motif":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 313 W e 33.9 8d82_F NET1_HUMAN:NETRIN-1[420 aa]:anti-IL-7R 2B8 Fab light chain[213 aa] 6 0 0 0 0 2 0 0 2 1 1 4 12 0 2 5 2 5 54 2 MOTIF:/note="WSXWS motif":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":MOTIF:/note="WSXWS motif":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 314 S b 9.4 8d82_F NET1_HUMAN:NETRIN-1[420 aa] NA A0A161FW14_MESMA:Dscam[288 aa] 3 2 0 0 3 4 0 0 0 1 3 0 0 0 1 73 4 5 0 0 MOTIF:/note="WSXWS motif":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":MOTIF:/note="WSXWS motif":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 315 E e 70.9 8d82_F NET1_HUMAN:NETRIN-1[420 aa] NA CRLF1_HUMAN:Cytokine receptor-like factor 1[303 aa] SO4 4 0 2 38 0 2 2 2 4 1 3 7 13 9 2 3 5 2 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 316 E e 37.7 8d82_F NET1_HUMAN:NETRIN-1[420 aa] NAG NA A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] SO4 6 0 1 33 2 0 0 2 6 3 0 0 18 10 3 6 3 5 1 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 317 A E b 16.1 8d82_F NET1_HUMAN:NETRIN-1[420 aa] NAG SO4 19 2 0 6 0 2 0 4 8 12 2 0 2 0 6 14 7 13 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 318 S E e 47.7 8d82_F NAG IL6A_HUMAN:A0A161FW14_MESMA:CRLF1_HUMAN:IL-6 Receptor alpha chain[299 aa]:Dscam[288 aa]:Dscam[275 aa]:Cytokine receptor-like factor 1[303 aa] SO4 4 0 1 4 4 5 5 1 2 4 4 2 2 2 16 18 17 3 3 5 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 319 G E b 11.9 8d82_F IL6A_HUMAN:IL-6 Receptor alpha chain[299 aa] GOL 9 0 1 1 6 21 4 9 1 3 3 2 6 2 5 4 10 8 0 3 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 320 I E e 57.9 8d82_F IL6A_HUMAN:CRLF1_HUMAN:IL-6 Receptor alpha chain[299 aa]:Cytokine receptor-like factor 1[303 aa] GOL 1 0 1 5 1 2 3 13 6 18 1 1 3 10 7 2 15 9 0 1 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 321 T b 0.6 8d82_F 2 0 3 1 0 2 0 2 2 0 1 0 8 0 2 6 66 5 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 322 Y e 25.7 8d82_F IL6A_HUMAN:DCC_HUMAN:IL-6 Receptor alpha chain[299 aa]:Netrin receptor DCC[195 aa]:Netrin receptor DCC[202 aa] 5 0 1 5 4 2 0 0 9 19 7 2 10 2 1 2 13 5 7 5 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 323 E b 15.1 8d82_F IL6A_HUMAN:DCC_HUMAN:IL-6 Receptor alpha chain[299 aa]:Netrin receptor DCC[195 aa] 5 0 6 54 0 0 0 1 1 3 1 2 4 10 5 1 5 2 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 324 D e 42.0 8d82_F IL6A_HUMAN:IL-6 Receptor alpha chain[299 aa] 25 0 19 17 0 4 0 4 8 2 0 0 0 4 2 5 7 3 0 0 DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 2":TOPO_DOM:/note="Extracellular" 325 R e 36.0 8d82_F 23 0 0 11 2 0 0 3 11 2 0 2 6 2 19 1 5 13 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 326 P b 3.1 8d82_F 1 0 3 3 2 0 0 0 0 2 0 0 83 0 0 1 3 2 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 327 S e 50.0 8d82_F NET1_HUMAN:NETRIN-1[420 aa] 7 1 6 4 0 5 0 2 2 6 4 1 3 5 8 33 9 4 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 328 K S e 39.6 8d82_F A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] 5 0 5 6 0 11 2 1 16 0 0 2 14 4 9 6 14 5 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 329 A e 46.4 8d82_F A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] 29 0 3 2 0 12 0 1 2 6 3 0 23 3 2 2 7 3 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 330 P b 0.8 8d82_F 1 0 0 6 0 1 0 2 2 11 2 0 68 0 0 0 3 2 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 331 S b 14.1 8d82_F CL A0A161FW14_MESMA:Dscam[275 aa] 6 0 23 11 0 4 0 1 4 1 0 5 14 6 3 17 5 1 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 332 F E b 2.9 8d82_F 5 0 6 1 12 2 2 7 1 12 2 5 3 4 6 5 9 18 0 1 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 333 W E b 4.8 8d82_F A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] EDO 6 1 4 5 1 2 1 2 4 7 3 1 2 2 3 2 2 8 43 1 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 334 Y E b 16.1 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] EDO 4 2 2 2 1 5 3 6 3 8 1 1 5 2 21 5 3 10 2 13 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 335 K E e 29.2 8d82_F EDO 6 2 5 9 1 4 5 11 8 5 2 3 4 11 7 5 3 9 0 1 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 336 I e 63.2 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] 6 1 1 2 1 7 1 20 2 18 3 1 1 1 5 2 5 21 0 3 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 337 D e 32.1 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] NAG 4 1 17 10 1 2 1 3 3 3 2 23 1 3 4 7 10 5 0 1 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 338 P e 90.7 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] NAG 2 0 1 2 3 6 0 3 1 5 0 1 41 11 1 3 3 12 0 5 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 339 S e 38.3 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] 11 8 7 4 3 1 3 2 6 2 1 3 1 4 5 22 11 3 2 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 340 H S e 85.3 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] NAG 9 2 7 4 1 9 10 2 3 4 2 3 1 6 11 13 6 2 6 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 341 T S e 48.1 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] NAG 3 0 4 9 1 7 0 2 1 1 7 4 2 9 2 13 21 13 0 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 342 Q S e 80.1 8d82_F DCC_HUMAN:I12R1_MOUSE:DAPK1_HUMAN:Netrin receptor DCC[95 aa]:Netrin receptor DCC[94 aa]:anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa]:Interleukin-12 receptor subunit beta-1,Death-assoc.. 3 0 2 4 1 9 3 6 7 6 0 8 5 18 3 14 5 4 0 1 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 343 G S e 56.0 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] 9 1 9 4 1 32 1 3 8 4 1 3 1 1 3 12 3 3 0 1 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 344 Y S e 73.5 8d82_F DCC_HUMAN:Netrin receptor DCC[95 aa]:Netrin receptor DCC[94 aa] NAG 7 1 3 11 4 10 1 3 4 8 1 5 3 1 11 13 6 5 0 3 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 345 R E b 19.8 8d82_F DCC_HUMAN:Netrin receptor DCC[95 aa]:Netrin receptor DCC[94 aa]:anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] NAG 2 0 3 4 1 5 4 1 10 2 1 1 3 7 38 9 5 3 0 1 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 346 T E b 16.9 8d82_F NAG 9 0 2 8 0 1 0 2 2 1 0 11 2 0 2 27 24 4 0 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 347 V E b 2.0 8d82_F 4 0 2 0 0 0 0 18 0 25 7 0 2 0 0 0 0 41 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 348 Q E e 35.7 8d82_F 0 0 0 2 4 0 0 10 0 19 0 4 0 7 20 7 15 12 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 349 L E b 3.9 8d82_F 0 0 0 0 0 0 0 19 0 49 4 0 0 0 0 3 0 26 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 350 V E b 13.3 8d82_F I12R1_MOUSE:DAPK1_HUMAN:Interleukin-12 receptor subunit beta-1,Death-assoc.. EDO 7 2 0 0 12 0 4 2 4 11 0 2 0 7 2 12 19 8 3 7 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 351 W E b 0.8 8d82_F 0 0 0 3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 94 4 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 352 K e 34.4 8d82_F CL 1 0 8 20 0 1 0 1 43 1 2 2 1 9 5 3 3 1 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 353 T e 57.8 8d82_F 6 1 4 5 1 8 1 2 5 3 1 4 38 1 2 7 8 2 0 3 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 354 L b 6.7 8d82_F A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] 5 3 1 2 1 2 1 3 4 39 1 1 11 1 5 2 3 14 0 1 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 355 P e 76.0 8d82_F A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] 1 0 3 1 0 1 0 1 5 4 5 5 51 1 6 14 2 1 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 356 P S e 68.2 8d82_F 3 0 2 7 0 11 0 5 13 8 0 0 41 0 4 0 4 1 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 357 F S e 76.1 8d82_F A0A161FW14_MESMA:Dscam[288 aa] 6 0 0 23 4 4 3 0 4 8 0 11 5 2 0 16 6 5 2 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 358 E S e 41.7 8d82_F NET1_HUMAN:NETRIN-1[420 aa] A0A161FW14_MESMA:Dscam[288 aa]:Dscam[275 aa] 2 0 12 32 4 0 4 0 2 9 0 2 4 7 4 7 6 2 0 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 359 A S b 7.1 8d82_F 26 0 5 2 0 11 4 0 0 4 0 0 17 11 0 10 2 3 2 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 360 N b 9.1 8d82_F 4 0 0 4 0 1 0 0 0 12 0 52 2 2 6 5 0 6 0 6 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 361 G S b 13.1 8d82_F 0 6 0 6 0 76 0 0 0 0 0 2 0 0 0 6 0 0 4 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 362 K e 72.2 8d82_F NAG 5 0 2 13 0 2 0 3 27 8 0 4 14 4 4 9 2 0 0 4 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 363 I e 31.0 8d82_F NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. EDO 0 2 0 0 0 10 0 56 4 4 0 2 2 0 0 0 3 15 0 3 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 364 L e 46.6 8d82_F NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. DCC_HUMAN:Netrin receptor DCC[202 aa] EDO 0 0 0 2 10 0 0 7 0 24 0 0 4 12 18 5 9 8 0 1 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 365 D E b 19.8 8d82_F DCC_HUMAN:Netrin receptor DCC[202 aa] SO4 3 0 8 5 3 32 4 0 2 0 0 7 0 11 4 13 4 0 0 3 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 366 Y E b 6.1 8d82_F EDO 3 0 0 0 3 0 0 0 0 0 0 0 0 0 4 4 2 2 0 83 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 367 E E b 11.1 8d82_F NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 0 0 0 9 0 0 4 6 13 7 0 16 0 13 7 8 3 10 0 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 368 V E b 2.0 8d82_F 2 0 0 3 0 1 0 18 0 18 0 0 0 0 0 1 0 52 0 3 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 369 T E b 13.0 8d82_F NAG SO4 10 0 0 3 3 7 0 5 5 0 2 3 8 3 6 19 8 9 2 8 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 370 L E b 8.4 8d82_F SO4 2 4 0 0 8 3 4 8 0 21 2 0 0 0 3 4 2 15 6 17 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 371 T E e 21.4 8d82_F 2 2 2 8 0 6 0 1 3 1 2 1 3 7 16 20 19 1 3 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 372 R E e 43.1 8d82_F 6 3 0 20 3 7 0 0 4 3 3 5 9 6 13 6 6 0 0 4 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 373 W T e 47.0 8d82_F 5 5 2 11 2 7 1 0 3 6 0 2 2 0 0 4 7 3 36 3 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 374 K T e 82.1 8d82_F NAG SO4 11 0 8 6 0 5 7 2 17 0 1 5 3 10 2 6 9 5 3 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 375 S T e 93.8 8d82_F 5 0 2 7 0 11 3 4 9 4 0 3 2 6 0 29 14 0 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 376 H E e 47.1 8d82_F SO4 2 0 2 8 0 9 25 0 6 2 2 6 5 4 0 8 12 4 0 4 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 377 L E e 74.2 8d82_F NAG 3 3 2 8 0 6 0 3 0 15 3 6 2 2 3 13 8 16 7 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 378 Q E e 29.6 8d82_F 4 0 0 12 0 3 2 0 2 4 0 11 7 20 5 17 8 2 2 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 379 N E e 83.6 8d82_F NAG alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. 6 0 12 11 0 2 2 2 5 5 3 16 2 2 7 9 8 4 0 2 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16335952":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16335952":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 380 Y E e 49.1 8d82_F 4 0 5 2 11 4 8 17 3 1 2 3 0 3 0 14 2 6 3 12 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 381 T E e 47.4 8d82_F 4 2 7 0 4 6 0 4 0 5 6 3 15 3 0 15 19 6 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 382 V E b 19.3 8d82_F beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. SO4 6 2 6 8 3 5 7 7 0 3 2 0 3 2 5 4 7 31 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 383 N S e 77.6 8d82_F I12R1_MOUSE:DAPK1_HUMAN:Interleukin-12 receptor subunit beta-1,Death-assoc.. NAG beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. EDO 1 0 5 6 0 3 4 4 5 4 0 30 6 5 2 8 12 0 4 2 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 384 A S e 44.6 8d82_F I12R1_MOUSE:DAPK1_HUMAN:Interleukin-12 receptor subunit beta-1,Death-assoc.. EDO:SO4 17 0 9 0 0 14 5 7 0 4 0 8 2 5 1 11 16 2 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 385 T S e 54.5 8d82_F I12R1_MOUSE:DAPK1_HUMAN:Interleukin-12 receptor subunit beta-1,Death-assoc.. EDO 6 0 0 0 2 0 6 0 0 0 0 5 7 2 2 21 41 3 1 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 386 K E e 49.5 8d82_F EDO:SO4 10 3 1 9 0 2 2 2 11 2 0 5 5 9 7 16 1 6 4 4 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 387 L E b 6.7 8d82_F I12R1_MOUSE:DAPK1_HUMAN:Interleukin-12 receptor subunit beta-1,Death-assoc.. SO4 8 6 0 4 16 0 0 10 0 29 0 2 0 0 2 2 7 10 1 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 388 T E e 55.8 8d82_F SO4 3 3 0 8 6 4 0 7 1 6 0 4 5 2 1 13 29 6 1 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 389 V E b 14.7 8d82_F 2 8 0 2 8 6 0 14 3 9 0 0 3 0 4 5 9 22 0 4 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 390 N E e 66.7 8d82_F NAG 2 0 8 7 3 8 8 4 3 11 0 26 5 3 6 2 2 0 0 2 CARBOHYD:/note="N-linked (GlcNAc...) (complex) asparagine" ECO:0000269|PubMed:19159218":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) (complex) asparagine" ECO:0000269|PubMed:19159218":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 391 L E b 6.7 8d82_F 2 2 0 0 3 6 0 13 0 29 0 3 4 2 7 7 3 10 6 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 392 T e 44.2 8d82_F NAG 2 0 3 5 3 2 2 2 2 22 0 1 9 0 8 5 29 2 0 3 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 393 N S e 50.9 8d82_F NAG 0 0 0 12 2 15 0 0 14 10 0 15 2 0 8 11 6 0 0 4 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 394 D S e 26.5 8d82_F 0 0 20 8 0 9 0 4 4 2 0 8 5 10 0 10 15 0 3 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 395 R e 39.5 8d82_F SO4 18 0 6 7 0 6 0 1 4 4 1 5 6 8 13 18 2 3 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 396 Y E b 2.2 8d82_F 0 2 0 6 4 5 6 0 5 0 0 0 5 4 0 5 2 8 5 41 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 397 L E e 43.8 8d82_F 4 0 0 8 0 0 2 12 14 14 2 2 5 2 2 3 12 10 5 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" L->V:LB/B:rs2228043: -; 398 A E b 6.2 8d82_F 22 0 0 0 9 1 0 18 0 4 0 2 5 0 1 2 4 17 0 14 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 399 T E e 26.6 8d82_F 9 2 2 3 4 2 2 0 8 0 0 5 8 0 13 15 22 1 0 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 400 L E b 0.6 8d82_F 0 0 0 0 7 0 0 7 0 26 2 4 0 0 0 2 6 39 0 3 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 401 T E b 7.8 8d82_F 10 3 3 5 0 3 0 4 12 6 0 0 0 4 3 16 19 11 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 402 V E b 2.7 8d82_F 53 0 0 0 3 0 3 5 0 3 0 2 2 0 0 4 2 23 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 403 R E e 34.4 8d82_F 5 0 0 4 2 9 2 3 10 6 0 6 0 0 18 0 9 14 0 11 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 404 N b 4.2 8d82_F 2 2 6 0 0 0 0 0 0 0 0 66 5 0 0 5 8 5 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" N->Y:LP/P:-: Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections (HIES4B) ; 405 L S e 57.9 8d82_F 5 0 10 2 2 8 0 3 3 5 2 12 0 0 2 33 0 11 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 406 V S e 42.7 8d82_F 17 0 0 3 2 4 0 11 16 7 3 2 1 3 0 4 2 24 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 407 G e 33.3 8d82_F 0 0 2 0 2 70 0 0 2 1 0 2 5 0 0 11 0 3 0 3 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 408 K B e 48.6 8d82_F NAG 13 0 9 16 0 2 0 0 21 5 0 0 4 0 2 16 10 0 2 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 409 S b 9.4 8d82_F 2 0 0 7 3 15 0 0 2 0 0 0 3 3 0 59 5 2 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 410 D e 65.4 8d82_F 7 0 20 13 0 0 0 0 7 6 0 0 23 5 2 10 3 2 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 411 A e 50.0 8d82_F 15 0 2 13 5 7 0 7 0 4 0 0 11 6 0 19 0 8 2 1 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 412 A E b 10.7 8d82_F 23 0 3 6 0 6 0 4 0 0 0 6 8 4 0 17 14 3 0 5 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 413 V E e 54.7 8d82_F 6 0 0 3 6 4 0 9 0 9 2 2 2 0 6 9 12 26 2 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 414 L E b 3.4 8d82_F 4 0 0 10 6 0 0 10 0 16 13 6 5 2 4 3 8 12 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 415 T E e 28.6 8d82_F 6 0 3 12 2 4 0 0 2 8 0 4 3 4 4 9 24 14 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" T->I:US:-: A colorectal cancer sample; 416 I E b 7.6 8d82_F 2 0 3 5 4 0 4 26 0 16 2 0 3 5 0 0 7 20 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 417 P b 5.4 8d82_F 4 4 0 0 8 1 0 2 10 4 4 2 25 3 4 14 7 4 0 3 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 418 A b 16.1 8d82_F 18 2 4 5 0 10 0 2 0 8 0 8 2 3 0 14 10 11 0 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 419 C T e 46.7 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] 10 9 10 4 0 1 0 2 4 10 0 2 2 2 5 12 7 11 8 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 420 D T e 77.8 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] 2 1 26 15 2 3 4 7 4 1 0 3 7 7 0 6 10 0 0 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 421 F e 26.3 8d82_F EDO 6 0 2 6 7 14 0 3 0 15 6 0 5 0 3 10 4 14 0 2 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 422 Q e 67.9 8d82_F EDO 10 0 0 17 0 8 4 0 7 4 0 2 15 13 4 10 4 1 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 423 A e 40.2 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] EDO 26 0 2 7 0 11 0 1 6 4 6 0 13 2 4 12 2 4 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 424 T e 30.5 8d82_F EDO 15 0 4 10 4 8 0 4 0 7 0 3 11 2 2 4 10 14 0 0 DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 3":TOPO_DOM:/note="Extracellular" 425 H S e 79.1 8d82_F EDO 24 0 3 5 1 6 7 1 3 4 0 5 12 7 1 9 4 7 0 1 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 426 P e 31.8 8d82_F EDO 12 2 1 5 1 7 0 4 3 1 0 1 42 2 4 7 4 2 0 3 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 427 V b 6.0 8d82_F 9 0 3 4 0 6 0 6 1 8 0 0 21 6 3 4 5 21 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 428 M e 52.7 8d82_F EDO:SO4 1 2 0 9 3 4 0 6 5 13 5 7 0 11 6 6 10 10 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 429 D e 58.0 8d82_F 6 3 15 5 2 3 4 1 1 3 2 15 1 4 1 20 10 8 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 430 L E b 13.5 8d82_F 7 0 0 6 7 2 0 8 0 26 4 0 3 0 4 3 4 23 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 431 K E e 35.4 8d82_F 6 0 3 3 0 0 4 0 17 8 0 1 5 11 4 16 16 4 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 432 A E e 21.4 8d82_F 37 0 5 6 0 8 0 2 1 5 0 5 2 0 0 17 2 9 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 433 F e 37.8 8d82_F LEPR_MOUSE:LEPR_HUMAN:Leptin receptor[593 aa]:Leptin receptor[596 aa] 4 7 0 9 7 0 4 10 0 2 4 1 0 4 2 9 8 16 0 11 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 434 P b 13.2 8d82_F CL LEPR_HUMAN:Leptin receptor[596 aa] EDO 8 0 4 7 0 13 4 2 2 1 0 6 27 2 3 8 5 6 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 435 K e 69.3 8d82_F LEPR_HUMAN:Leptin receptor[596 aa] 7 0 0 6 0 8 5 2 8 8 4 8 5 4 8 14 10 3 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 436 D S e 40.7 8d82_F LEPR_MOUSE:LEPR_HUMAN:Leptin receptor[593 aa]:Leptin receptor[596 aa] 4 0 19 13 0 9 0 5 6 0 1 6 5 0 0 24 7 0 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 437 N S e 74.5 8d82_F 0 0 9 7 0 7 2 0 5 0 0 20 2 0 2 25 20 0 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 438 M S e 30.4 8d82_F EDO 8 4 0 13 2 9 0 6 2 12 7 0 0 2 8 11 5 10 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 439 L b 1.1 8d82_F EDO 5 0 0 0 7 0 0 32 0 24 4 0 0 0 2 4 7 15 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 440 W E e 21.1 8d82_F LEPR_MOUSE:LEPR_HUMAN:Leptin receptor[593 aa]:Leptin receptor[596 aa] 1 0 1 7 9 3 0 6 1 20 3 7 1 3 1 7 6 5 20 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 441 V E b 0.7 8d82_F LEPR_MOUSE:Leptin receptor[593 aa] 5 0 0 0 0 0 0 26 4 24 5 0 0 0 2 0 0 34 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 442 E E b 14.1 8d82_F LEPR_MOUSE:LEPR_HUMAN:Leptin receptor[593 aa]:Leptin receptor[596 aa] 7 0 4 3 0 5 8 0 3 0 0 2 2 8 10 30 13 3 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 443 W E b 6.8 8d82_F 0 0 0 0 0 2 0 0 0 0 0 0 4 0 3 0 0 0 91 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 444 T e 39.0 8d82_F 4 0 7 10 0 3 3 2 9 5 0 9 4 21 3 10 11 0 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 445 T e 42.9 8d82_F EDO 8 0 0 3 0 0 9 0 0 9 0 2 35 0 7 9 7 6 1 2 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 446 P b 14.7 8d82_F 2 0 5 0 0 3 0 1 0 3 0 6 58 3 0 5 0 12 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 447 R S e 85.4 8d82_F 5 0 1 1 0 5 3 2 10 6 0 5 18 6 14 13 5 2 2 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 448 E S e 38.2 8d82_F EDO 2 0 8 26 0 18 0 0 15 6 0 7 5 4 5 3 0 0 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 449 S e 89.8 8d82_F EDO 10 0 18 5 0 2 0 2 2 5 5 1 8 4 10 20 5 0 2 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 450 V b 14.0 8d82_F EDO 4 0 0 0 0 6 0 12 5 15 0 2 7 0 0 7 11 27 0 2 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 451 K S e 49.5 8d82_F 1 5 2 3 0 10 0 11 5 10 4 10 8 11 10 3 2 6 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 452 K E b 11.3 8d82_F 3 0 5 6 0 36 0 0 8 0 1 12 3 6 8 2 3 2 0 6 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 453 Y E b 0.9 8d82_F 2 0 0 1 4 9 7 2 5 5 0 0 0 4 5 0 3 2 3 47 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 454 I E b 0.0 8d82_F 0 0 0 7 3 2 0 31 2 12 2 0 2 3 4 2 0 30 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" I->T:LB/B:rs2228046: -; 455 L E b 1.7 8d82_F 0 0 0 0 4 1 3 19 2 30 0 0 0 11 0 0 4 23 0 3 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 456 E E b 18.6 8d82_F EDO 3 0 9 25 0 15 4 0 12 2 0 2 0 7 4 0 2 6 0 7 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 457 W E b 4.8 8d82_F EDO 0 0 5 0 0 4 0 2 0 1 0 0 0 0 0 2 0 0 47 36 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 458 C E b 11.3 8d82_F EDO 15 15 1 6 6 4 0 1 12 3 0 3 1 1 13 5 2 4 5 4 DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 459 V E e 30.7 8d82_F LEPR_MOUSE:Leptin receptor[593 aa] EDO 13 0 3 9 2 1 0 9 2 11 2 11 6 4 5 3 4 14 0 2 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 460 L e 29.2 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] 7 0 6 2 3 3 7 6 4 26 5 1 1 5 7 10 1 2 2 3 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 461 S e 48.4 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] LEPR_HUMAN:Leptin receptor[596 aa] 4 0 4 5 0 9 6 2 3 4 2 6 4 3 1 25 8 2 0 12 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 462 D T e 53.1 8d82_F LEPR_HUMAN:Leptin receptor[596 aa] 1 0 20 10 0 5 2 0 2 2 0 2 8 11 14 13 2 2 4 2 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 463 K T e 102.8 8d82_F LEPR_HUMAN:Leptin receptor[596 aa] 1 0 14 8 0 12 4 0 14 2 0 2 4 4 8 20 5 1 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 464 A S e 43.8 8d82_F 12 0 8 19 2 12 1 0 8 9 0 2 2 5 5 6 5 3 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 465 P e 93.0 8d82_F 5 0 2 13 2 4 0 1 1 4 0 3 32 4 10 11 3 3 0 1 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 466 C e 40.0 8d82_F 6 13 4 7 1 8 1 4 4 3 1 6 4 5 5 17 4 5 2 1 DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DISULFID:ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 467 I e 98.2 8d82_F EDO 4 0 8 5 3 2 2 9 4 25 2 1 3 1 7 8 6 8 0 3 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 468 T e 22.1 8d82_F EDO 2 0 1 2 3 5 0 5 7 14 4 3 5 3 6 15 17 6 0 1 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 469 D E e 46.3 8d82_F EDO 1 0 20 8 4 5 3 1 10 6 0 4 3 11 3 11 3 3 0 3 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 470 W E b 6.0 8d82_F EDO 3 0 0 4 0 1 0 6 5 3 3 2 0 0 2 3 0 6 53 9 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 471 Q E b 2.0 8d82_F CL 2 0 0 15 0 0 3 2 15 11 2 5 0 16 7 8 7 5 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 472 Q E e 26.0 8d82_F CL 3 0 0 11 2 0 1 2 13 3 2 20 1 9 16 4 5 6 1 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 473 E E b 10.1 8d82_F 0 0 7 18 2 2 3 9 5 8 0 4 2 3 7 11 2 18 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 474 D E e 63.0 8d82_F 1 0 15 7 0 5 0 3 3 3 0 8 16 5 1 19 7 4 0 2 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 475 G S b 13.1 8d82_F EDO 5 0 2 4 0 28 0 2 5 6 0 2 16 5 2 12 3 5 0 2 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 476 T S e 78.6 8d82_F 4 0 1 5 2 6 2 5 7 0 4 15 0 3 2 12 25 4 0 3 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 477 V e 24.7 8d82_F 6 3 0 3 7 0 0 9 7 6 0 6 3 8 6 6 14 17 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 478 H S e 60.7 8d82_F LEPR_MOUSE:Leptin receptor[593 aa] 2 0 3 12 0 4 7 2 5 7 1 7 2 7 3 4 25 4 0 5 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 479 R E e 37.5 8d82_F LEPR_MOUSE:LEPR_HUMAN:Leptin receptor[593 aa]:Leptin receptor[596 aa] 1 0 4 5 0 6 2 0 9 2 0 4 3 0 23 22 6 4 3 5 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 480 T E b 18.2 8d82_F LEPR_MOUSE:Leptin receptor[593 aa] 11 0 0 2 7 2 0 4 2 5 0 0 2 7 5 14 28 7 0 4 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 481 Y E e 36.5 8d82_F LEPR_MOUSE:LEPR_HUMAN:Leptin receptor[593 aa]:Leptin receptor[596 aa] 4 3 2 3 4 0 4 8 15 14 3 2 0 2 6 0 0 9 0 19 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 482 L b 3.9 8d82_F EDO 2 0 0 5 1 0 0 29 3 31 0 0 0 4 4 2 8 9 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 483 R e 41.1 8d82_F CL LEPR_MOUSE:Leptin receptor[593 aa] 3 0 4 7 7 0 9 5 10 7 0 0 4 5 15 11 4 7 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 484 G S e 54.8 8d82_F EDO 6 0 13 17 2 32 0 1 1 1 0 0 1 2 3 11 7 4 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 485 N e 106.1 8d82_F LEPR_HUMAN:Leptin receptor[596 aa] EDO 1 0 10 6 1 9 7 1 4 2 0 34 3 2 7 2 5 4 0 1 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 486 L b 18.5 8d82_F LEPR_MOUSE:Leptin receptor[593 aa] EDO 2 0 0 0 8 2 0 8 0 64 0 0 0 2 3 3 2 5 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 487 A e 41.1 8d82_F LEPR_MOUSE:LEPR_HUMAN:Leptin receptor[593 aa]:Leptin receptor[596 aa] 4 0 2 12 4 0 3 4 25 2 0 2 0 7 3 11 11 5 0 3 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 488 E T e 49.2 8d82_F LEPR_MOUSE:LEPR_HUMAN:Leptin receptor[593 aa]:Leptin receptor[596 aa] 5 0 3 15 0 7 0 0 8 0 0 0 44 1 7 4 4 1 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 489 S T e 28.9 8d82_F LEPR_MOUSE:LEPR_HUMAN:Leptin receptor[593 aa]:Leptin receptor[596 aa] 0 0 8 5 17 17 4 4 2 0 0 15 4 3 0 4 0 2 0 13 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 490 K e 39.6 8d82_F LEPR_MOUSE:LEPR_HUMAN:Leptin receptor[593 aa]:Leptin receptor[596 aa] 0 0 0 4 0 5 3 6 7 3 0 4 0 4 5 17 28 12 2 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 491 C b 6.7 8d82_F LEPR_MOUSE:LEPR_HUMAN:Leptin receptor[593 aa]:Leptin receptor[596 aa] SO4 9 10 0 8 5 0 4 6 4 17 4 3 7 2 6 3 4 5 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 492 Y E b 8.3 8d82_F EDO 0 0 0 0 9 0 0 0 0 1 0 0 0 0 3 0 2 0 0 81 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 493 L E e 21.3 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] EDO 2 0 0 19 2 5 8 6 2 8 0 10 0 5 12 11 2 2 0 6 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 494 I E b 0.0 8d82_F EDO 2 0 0 0 27 0 0 37 0 18 7 0 0 0 0 0 2 3 0 4 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 495 T E b 14.9 8d82_F EDO 4 0 2 0 4 2 0 2 4 0 0 6 0 5 25 18 24 0 2 1 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 496 V E b 6.0 8d82_F 10 2 0 2 0 0 0 9 0 15 2 0 3 0 0 0 3 53 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 497 T E b 4.5 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] 13 0 0 2 0 0 3 2 4 3 0 2 3 4 23 10 11 0 0 20 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 498 P E b 1.6 8d82_F 51 0 0 0 4 4 0 0 0 1 0 8 18 0 3 2 2 5 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" P->L:LP/P:-: Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections (HIES4B) ; 499 V E b 4.0 8d82_F 5 8 0 2 6 0 0 14 0 12 4 0 0 3 6 2 2 24 0 11 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" V->I:LB/B:rs3441793: -; 500 Y E b 12.2 8d82_F EDO 6 0 0 0 12 1 0 5 5 4 0 24 0 2 2 9 14 3 0 11 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 501 A T e 82.1 8d82_F 10 2 2 7 0 26 2 1 2 4 6 9 4 2 2 12 1 3 3 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 502 D T e 57.4 8d82_F EDO 20 0 10 25 0 6 2 2 5 2 2 4 0 9 0 2 5 3 0 3 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 503 G E b 4.8 8d82_F EDO 0 0 0 0 2 69 0 2 2 0 0 2 3 3 2 10 2 0 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 504 P E b 7.0 8d82_F EDO 2 6 5 5 0 8 0 2 2 4 2 3 16 11 0 4 4 15 0 10 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 505 G b 9.5 8d82_F EDO 11 0 0 0 0 63 0 3 0 2 0 0 2 5 3 3 2 0 4 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 506 S e 25.0 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] 8 4 0 5 0 3 4 0 6 13 3 5 15 0 2 26 2 2 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 507 P e 42.6 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] 9 2 4 1 0 1 0 1 1 8 0 0 41 4 4 18 4 3 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 508 E E e 25.6 8d82_F SO4 5 0 3 21 3 2 2 0 6 0 0 2 9 6 9 20 2 6 0 2 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 509 S E e 55.5 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] 2 0 0 6 0 0 2 3 9 3 0 2 12 9 3 32 13 2 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 510 I E e 21.6 8d82_F CL 4 0 3 0 3 0 0 23 3 7 2 0 3 9 0 4 5 28 4 2 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 511 K E e 54.7 8d82_F anti-mLEPR VHH 4-80[129 aa]:anti-mLEPR VHH 4-80[128 aa] CL SO4 0 0 3 16 6 0 0 7 16 2 4 9 0 4 12 4 6 5 2 4 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 512 A E b 5.4 8d82_F EDO 16 0 3 3 6 28 0 3 2 4 0 0 0 0 6 5 10 14 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 513 Y b 4.3 8d82_F CL LEPR_MOUSE:Leptin receptor[593 aa] EDO 0 4 6 0 18 0 0 3 2 0 0 6 0 0 13 0 18 6 4 20 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 514 L S b 10.7 8d82_F CL 4 0 0 2 0 0 0 4 4 12 0 0 0 0 3 11 46 12 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 515 K S e 50.5 8d82_F CL 5 0 6 21 0 12 0 0 18 0 2 2 9 15 4 4 3 0 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 516 Q e 28.6 8d82_F CL EDO 2 0 2 47 0 0 6 0 10 0 0 0 5 11 8 4 0 0 4 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" 517 A e 25.9 8d82_F 32 0 4 0 0 10 2 0 6 13 2 0 2 0 2 15 11 0 0 0 DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 4":TOPO_DOM:/note="Extracellular" A->P:LP/P:-: Hyper-IgE syndrome 4B, autosomal recessive, with recurrent infections (HIES4B) ; 518 P b 19.4 8d82_F 35 0 0 0 0 0 0 0 1 2 4 0 31 0 4 0 4 16 0 2 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 519 P b 0.0 8d82_F 2 0 0 0 4 0 0 0 0 0 0 0 81 0 0 2 0 10 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 520 S S e 60.2 8d82_F 10 0 5 2 0 4 0 4 0 15 0 0 6 4 7 37 3 2 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 521 K S e 33.5 8d82_F 21 0 2 8 0 7 4 0 3 3 3 0 12 12 4 11 0 10 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 522 G b 14.3 8d82_F 15 0 0 0 0 24 0 2 0 3 5 6 29 2 6 0 0 8 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 523 P b 2.3 8d82_F 1 3 3 2 0 0 0 4 0 0 2 0 72 4 2 4 2 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 524 T e 27.3 8d82_F I12R1_MOUSE:DAPK1_HUMAN:Interleukin-12 receptor subunit beta-1,Death-assoc.. 8 0 6 7 0 6 8 0 5 0 0 21 8 3 2 15 8 3 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 525 V b 0.0 8d82_F 3 0 0 0 4 0 0 16 0 27 0 5 5 0 0 4 3 34 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 526 R B e 34.8 8d82_F 5 0 3 5 0 3 6 6 14 6 1 4 0 5 17 5 17 3 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 527 T e 32.5 8d82_F 16 9 0 0 0 4 4 12 2 14 0 0 0 0 0 2 6 28 3 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 528 K e 72.6 8d82_F 2 0 2 10 2 2 4 8 13 7 0 1 4 10 3 6 7 13 5 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 529 K e 47.2 8d82_F EDO 13 0 10 9 0 1 4 0 6 0 2 11 5 7 4 13 8 2 0 2 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 530 V e 79.3 8d82_F 12 0 2 8 0 0 0 9 0 15 1 0 9 4 7 6 9 14 0 4 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 531 G S e 29.8 8d82_F CL EDO 5 0 2 10 3 22 0 0 2 7 0 0 7 2 2 20 19 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 532 K S e 50.9 8d82_F CL 16 0 3 4 0 2 0 0 15 5 0 5 12 0 7 17 5 6 2 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 533 N S e 45.5 8d82_F CL 0 0 10 2 0 11 4 0 1 0 0 14 0 5 1 24 27 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 534 E e 41.7 8d82_F CL EDO 3 2 0 5 0 0 0 0 5 0 1 2 0 9 4 52 12 0 4 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 535 A b 17.9 8d82_F 14 0 0 0 6 0 0 21 0 21 5 0 3 0 0 5 0 22 0 2 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 536 V b 13.3 8d82_F EDO 2 2 3 5 4 0 0 6 2 17 2 0 0 8 5 12 13 21 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 537 L b 2.8 8d82_F 4 0 0 0 0 0 0 14 0 45 0 0 0 0 0 0 0 37 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 538 E B b 5.5 8d82_F 8 0 0 13 3 6 2 0 10 0 2 7 0 8 6 23 11 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 539 W b 6.8 8d82_F 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 97 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 540 D e 56.2 8d82_F 1 0 26 23 1 4 0 1 8 1 0 2 3 5 3 6 3 11 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 541 Q e 75.5 8d82_F 3 0 11 14 1 2 10 1 1 2 0 1 28 11 1 3 1 5 3 1 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 542 L b 1.1 8d82_F 2 1 1 4 1 2 1 15 2 12 3 1 19 1 1 2 6 20 0 7 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 543 P e 31.8 8d82_F 2 0 5 0 0 1 4 1 11 1 0 0 67 0 3 2 0 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 544 V H e 31.3 8d82_F 18 0 3 2 2 0 0 0 7 8 0 0 31 0 4 4 5 12 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 545 D H e 54.3 8d82_F 7 0 20 19 0 0 4 0 3 11 5 3 2 3 4 10 3 3 0 4 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 546 V H e 31.3 8d82_F 6 0 3 16 4 1 9 5 9 3 2 6 3 6 7 14 4 2 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 547 Q H b 14.3 8d82_F 5 0 3 0 0 8 0 0 0 12 0 11 16 28 9 0 2 2 4 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 548 N b 7.3 8d82_F 9 0 2 11 0 6 2 0 6 2 4 45 2 0 9 2 0 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 549 G S b 0.0 8d82_F 3 0 0 0 0 77 0 4 0 0 0 0 0 0 0 16 0 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 550 F e 35.4 8d82_F EDO 4 6 9 11 14 0 4 20 2 1 2 3 8 3 3 0 4 6 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 551 I e 32.2 8d82_F 9 0 0 0 0 0 0 55 0 15 0 0 0 0 0 0 0 21 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 552 R e 52.6 8d82_F beta-D-mannopyranose-(1-4)-beta-D-mannopyranose-(1..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 1 0 6 0 0 0 11 5 10 2 1 0 12 20 0 29 3 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 553 N E e 39.4 8d82_F beta-D-mannopyranose-(1-4)-beta-D-mannopyranose-(1..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 4 9 0 47 16 0 5 0 0 8 0 5 4 4 0 0 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine" ECO:0000269|PubMed:20489211":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 554 Y E b 2.6 8d82_F 0 0 0 0 0 0 0 0 0 0 0 0 0 4 0 0 0 0 0 96 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 555 T E b 15.6 8d82_F 4 0 0 4 0 0 5 2 19 11 2 2 0 0 14 6 21 6 0 3 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 556 I E b 0.6 8d82_F 0 0 0 0 6 0 0 38 0 14 0 0 0 0 0 0 0 41 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 557 F E b 16.3 8d82_F EDO 3 4 0 3 22 8 6 5 6 6 0 3 0 1 0 7 3 0 2 22 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 558 Y E b 10.4 8d82_F EDO 2 0 0 0 9 0 0 4 0 4 3 0 0 0 5 0 0 2 12 56 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 559 R E e 21.3 8d82_F CL EDO 2 0 0 8 2 5 0 0 8 0 0 0 5 15 44 3 6 0 1 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 560 T b 14.3 8d82_F EDO 12 0 2 18 0 2 3 4 0 4 3 2 10 9 2 8 17 1 1 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 561 I S e 72.5 8d82_F 9 2 5 4 0 7 0 7 6 11 0 4 3 6 6 4 3 18 0 4 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 562 I S e 83.6 8d82_F NAG 3 0 12 8 6 13 0 8 0 10 0 2 4 8 6 8 2 8 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 563 G e 46.4 8d82_F NAG 1 0 3 4 0 34 2 1 1 3 0 3 10 13 5 18 4 1 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 564 N e 62.4 8d82_F NAG 0 0 7 16 0 4 13 0 11 0 0 21 5 4 7 12 0 0 0 0 CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":CARBOHYD:/note="N-linked (GlcNAc...) asparagine":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 565 E e 32.7 8d82_F CL EDO 4 0 11 34 0 5 3 0 6 6 0 5 0 0 2 14 4 0 5 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 566 T E e 37.0 8d82_F 0 5 7 5 9 4 0 0 4 3 2 1 0 6 6 15 21 11 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 567 A E e 56.2 8d82_F 4 5 11 18 0 2 7 0 15 0 0 0 2 1 2 15 5 8 0 4 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 568 V E e 31.3 8d82_F 8 0 0 1 5 1 3 22 6 13 3 0 2 1 7 0 7 20 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 569 N E e 58.2 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 4 0 5 0 2 1 9 4 13 8 2 13 7 5 2 6 11 4 3 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 570 V E b 11.3 8d82_F 0 0 0 3 3 0 0 17 2 12 0 0 6 0 0 4 3 43 0 6 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 571 D E e 37.0 8d82_F 3 0 25 6 4 3 2 3 5 0 0 14 10 0 7 10 6 2 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 572 S S e 23.4 8d82_F 19 0 8 5 0 11 0 6 3 5 0 3 2 0 5 16 10 3 0 4 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 573 S S e 78.9 8d82_F 5 0 3 5 2 6 1 3 8 0 0 13 5 4 3 33 8 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 574 H e 52.4 8d82_F 6 0 5 16 0 0 17 3 7 8 0 0 3 14 3 5 12 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 575 T e 51.9 8d82_F 3 2 3 6 4 0 2 0 8 9 0 12 4 5 9 8 25 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 576 E B e 37.7 8d82_F 8 0 2 14 0 3 2 0 8 0 2 3 3 5 7 27 11 0 0 4 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 577 Y e 22.2 8d82_F EDO 4 3 0 3 12 0 6 2 4 16 0 0 0 3 0 0 0 16 7 21 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 578 T e 46.1 8d82_F EDO 3 0 4 1 0 4 0 11 7 7 0 0 5 0 11 1 34 11 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 579 L b 7.9 8d82_F 6 0 0 2 2 0 0 23 0 44 3 0 0 0 0 0 3 17 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 580 S e 37.5 8d82_F 9 0 3 18 0 7 2 0 11 1 0 3 9 5 0 16 3 11 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 581 S S e 78.9 8d82_F EDO 0 0 10 0 0 16 2 0 6 0 0 27 15 1 3 17 3 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 582 L b 9.0 8d82_F EDO 0 0 0 0 3 0 0 3 0 86 0 0 0 0 0 0 0 5 0 3 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 583 T e 53.2 8d82_F EDO 0 0 6 13 2 0 6 3 10 5 0 4 10 16 6 8 9 3 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 584 S S e 41.4 8d82_F 2 0 1 16 5 8 0 0 9 3 0 0 29 0 7 12 2 3 3 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 585 D S e 80.2 8d82_F 10 0 17 5 6 12 3 0 7 0 0 13 0 0 7 8 0 0 6 6 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 586 T b 10.4 8d82_F 3 0 0 4 0 7 0 2 4 0 2 0 3 3 6 20 36 6 0 3 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 587 L E e 47.2 8d82_F 2 3 2 11 5 0 8 0 2 19 0 0 3 8 5 13 11 8 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 588 Y E b 12.2 8d82_F EDO 0 0 0 3 0 0 0 3 3 0 0 0 0 0 0 0 0 0 0 92 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 589 M E b 19.8 8d82_F CL EDO 0 0 0 17 0 0 10 16 6 8 7 0 0 4 6 4 4 16 1 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 590 V E b 4.0 8d82_F EDO 0 0 0 0 24 0 0 27 0 14 0 0 0 0 0 0 0 28 5 3 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 591 R E b 19.0 8d82_F CL EDO 0 1 0 17 4 0 3 0 0 2 0 0 0 5 25 5 8 9 15 6 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 592 M E b 0.5 8d82_F 0 0 0 0 4 0 0 12 0 15 12 0 0 0 0 0 8 49 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 593 A E b 2.7 8d82_F EDO 16 0 0 0 0 0 0 0 11 3 7 0 0 7 26 3 12 12 0 4 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 594 A E b 0.0 8d82_F 81 0 0 0 0 0 0 2 0 2 0 0 7 0 0 8 0 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 595 Y E e 45.2 8d82_F EDO 2 3 0 0 23 0 8 0 3 4 4 0 0 4 5 7 10 8 3 14 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 596 T b 5.2 8d82_F 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 0 0 0 0 0 0 0 3 0 0 0 27 0 0 0 15 48 3 0 3 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 597 D S e 72.2 8d82_F beta-D-mannopyranose-(1-4)-beta-D-mannopyranose-(1..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 22 0 17 6 0 3 2 0 0 1 2 4 0 2 7 28 3 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 598 E S e 66.3 8d82_F beta-D-mannopyranose-(1-4)-beta-D-mannopyranose-(1..:2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. 44 0 6 11 0 10 0 0 1 4 0 0 0 3 3 1 1 15 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 599 G b 15.5 8d82_F beta-D-mannopyranose-(1-4)-beta-D-mannopyranose-(1.. 1 0 0 1 0 87 0 0 0 1 0 0 0 5 0 1 0 1 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 600 G E e 27.4 8d82_F EDO 8 4 2 2 1 41 1 2 2 3 2 1 2 1 6 13 2 2 0 5 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 601 K E e 40.1 8d82_F 6 1 11 2 1 18 1 6 5 3 1 2 12 1 2 10 9 7 0 1 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 602 D E e 57.4 8d82_F EDO 0 0 24 10 2 10 2 0 0 2 0 12 24 9 0 3 0 1 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 603 G e 20.2 8d82_F 3 0 0 0 0 61 0 3 0 5 0 0 0 0 0 22 5 0 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 604 P e 38.0 8d82_F 5 0 3 0 0 3 0 0 0 0 0 6 52 0 2 13 9 2 0 5 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 605 E e 39.7 8d82_F EDO 0 0 0 42 0 3 0 3 3 0 0 7 0 3 13 15 0 3 7 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 606 F E e 39.2 8d82_F 4 0 1 18 10 1 0 10 7 16 0 1 1 1 8 18 5 1 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 607 T E e 50.0 8d82_F 13 0 1 15 5 1 0 6 1 1 0 4 1 9 4 10 29 1 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 608 F E e 27.8 8d82_F 1 0 0 1 36 1 0 21 1 13 6 0 0 0 0 1 6 9 0 2 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 609 T E e 65.6 8d82_F 0 5 0 0 0 0 7 0 4 0 3 0 0 8 16 21 23 12 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 610 T b 8.4 8d82_F 5 2 2 5 0 0 0 7 0 12 0 0 0 0 8 4 48 6 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 611 P e 29.5 8d82_F 0 0 0 0 0 0 0 0 7 6 0 0 75 4 0 0 0 5 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 612 K e 78.3 8d82_F 1 0 11 18 0 1 7 6 16 1 0 1 1 6 1 14 4 11 0 0 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 613 F 5 0 1 1 16 10 0 15 1 4 5 7 1 4 3 3 7 10 0 7 DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular":DOMAIN:/note="Fibronectin type-III 5":TOPO_DOM:/note="Extracellular" 614 A 21 0 10 1 0 16 0 0 8 4 0 0 0 0 5 27 0 4 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 615 Q 7 0 4 9 0 7 0 0 4 0 0 3 11 15 7 11 7 13 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 616 G 7 0 0 0 5 33 5 0 0 7 0 7 6 0 0 17 11 0 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 617 E 0 0 3 20 0 0 12 4 13 7 5 4 0 15 4 6 0 0 3 3 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 618 I 5 0 0 0 0 0 3 41 3 12 0 0 4 11 0 3 0 13 4 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 619 E 15 0 7 15 4 3 0 14 0 6 0 6 4 4 11 8 0 3 0 0 TOPO_DOM:/note="Extracellular":TOPO_DOM:/note="Extracellular" 620 A 35 0 0 0 4 7 0 4 0 21 0 0 0 6 0 4 5 8 4 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 621 I 0 0 0 0 18 4 0 29 4 12 4 0 12 3 0 4 0 7 4 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 622 V 9 0 0 0 0 11 0 13 0 20 0 0 0 4 0 10 6 27 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 623 V 24 0 0 0 8 4 0 25 0 19 0 0 0 0 0 10 0 11 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 624 P 0 0 0 0 5 5 4 5 4 11 0 0 53 0 0 13 0 0 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 625 V 0 0 0 4 0 5 0 19 0 14 7 0 10 0 0 8 5 24 5 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 626 C 14 23 0 0 10 7 0 0 0 13 0 0 4 0 0 17 12 0 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 627 L 0 0 0 0 6 12 0 12 0 37 3 5 0 0 0 4 4 19 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 628 A 34 8 0 0 0 15 0 0 11 5 0 0 4 4 3 5 4 7 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 629 F 0 5 0 0 24 5 4 11 0 26 4 0 0 0 0 0 0 20 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 630 L 0 0 0 0 8 0 0 21 0 52 0 0 0 0 0 0 10 4 5 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 631 L 0 5 0 0 10 5 0 4 0 32 6 0 0 0 0 10 16 9 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 632 T 5 5 0 0 0 9 0 0 0 22 0 6 0 0 0 17 21 12 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 633 T 10 5 0 0 0 13 0 8 0 6 0 0 0 0 0 4 31 19 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 634 L 1 5 0 0 6 5 0 15 0 17 4 0 0 0 0 10 9 24 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 635 L 1 0 0 0 10 1 0 10 4 19 5 0 0 0 0 11 15 20 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 636 G 6 0 0 0 0 29 0 5 0 1 0 10 0 0 0 23 13 10 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 637 V 1 5 1 1 5 1 0 31 1 1 5 0 1 0 1 1 9 31 5 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 638 L 4 0 0 0 10 6 3 9 0 31 12 0 0 0 5 0 5 6 6 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 639 F 1 6 1 1 13 1 5 6 1 18 6 0 1 0 12 1 1 9 0 17 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 640 C 0 76 0 0 7 10 0 0 0 0 0 0 0 0 0 6 0 0 0 0 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 641 F 0 6 0 0 25 0 0 0 0 23 0 0 0 3 4 5 0 0 0 33 TRANSMEM:/note="Helical":TRANSMEM:/note="Helical" 642 N 7 0 0 0 0 0 6 0 11 5 0 9 5 15 25 0 7 0 9 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 643 K 14 0 0 0 0 0 0 7 55 6 0 5 0 7 6 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 644 R 4 0 0 0 0 0 0 0 7 0 0 0 10 7 54 15 0 3 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 645 D 0 7 10 14 8 7 0 0 7 1 0 11 9 16 0 0 0 7 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 646 L 1 0 1 1 7 1 0 1 6 27 0 1 1 1 6 1 5 11 29 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 647 I 1 0 1 1 0 1 8 39 1 27 0 1 1 1 1 1 1 17 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 648 K 0 0 0 0 0 0 0 0 56 17 0 0 7 0 0 0 12 0 8 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 649 K 4 0 0 32 0 0 6 0 11 0 0 6 6 0 23 5 7 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 650 H 4 0 0 0 0 0 19 0 11 12 0 0 14 0 0 7 26 0 7 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 651 I 0 29 0 0 22 0 0 19 0 15 0 0 0 8 0 0 0 7 0 0 MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic":MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic" 652 W 0 6 0 0 0 0 0 0 5 0 0 0 0 0 4 0 0 0 53 32 MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic":MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic" 653 P 0 4 0 15 0 0 0 0 4 0 0 0 70 0 0 7 0 0 0 0 MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic":MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic" 654 N 0 0 45 4 0 0 0 0 7 0 0 11 0 9 8 10 6 0 0 0 MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic":MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic" 655 V 0 0 0 0 0 0 0 48 0 0 0 0 0 0 0 0 0 52 0 0 MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic":MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic" 656 P 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic":MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic" 657 D 0 0 62 0 0 0 0 0 0 0 0 38 0 0 0 0 0 0 0 0 MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic":MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic" 658 P 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic":MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic" 659 S 57 0 0 15 0 0 0 0 0 0 0 0 0 0 0 11 0 0 0 17 MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic":MOTIF:/note="Box 1 motif":TOPO_DOM:/note="Cytoplasmic" 660 K 0 0 0 12 0 0 13 0 28 0 0 47 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 661 S 0 15 0 0 0 0 0 0 0 0 0 0 0 0 0 85 0 0 0 0 MOD_RES:/note="Phosphoserine":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine":TOPO_DOM:/note="Cytoplasmic" 662 H 0 0 0 0 0 0 12 0 16 0 0 8 0 0 0 51 14 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 663 I 16 5 0 0 0 0 0 35 0 20 0 0 0 0 0 16 0 0 9 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 664 A 45 0 0 0 0 27 0 0 0 20 0 0 0 0 0 8 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 665 Q 0 0 0 0 0 0 0 0 16 0 0 0 0 52 0 16 15 0 0 0 TOPO_DOM:/note="Cytoplasmic":TOPO_DOM:/note="Cytoplasmic" 666 W 1 0 1 1 18 1 0 1 18 2 0 1 1 1 1 1 1 1 47 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 667 S 3 1 2 2 1 3 1 2 2 14 1 2 2 2 2 22 2 13 0 23 MOD_RES:/note="Phosphoserine" ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine" ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 668 P 2 0 1 2 1 2 1 1 1 2 1 1 76 1 1 2 1 2 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 669 H 2 1 1 2 1 2 35 15 2 2 1 1 1 1 1 2 26 2 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 670 T 2 1 1 2 1 2 1 26 2 2 13 1 1 1 1 2 23 16 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 671 P 3 1 2 16 2 3 1 2 2 4 25 2 24 2 2 3 2 3 1 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 672 P 2 1 1 27 1 2 1 1 2 2 1 1 37 1 1 2 14 2 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 673 R 1 0 1 25 0 1 0 1 15 15 0 1 1 1 22 1 1 1 0 14 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 674 H 1 0 13 13 0 15 22 14 15 1 0 1 1 1 1 1 1 1 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 675 N 13 0 15 1 0 1 0 1 14 1 0 22 1 14 1 1 13 1 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 676 F 1 0 1 14 47 15 0 1 1 15 0 1 1 1 1 1 1 1 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 677 N 3 1 2 2 15 3 1 2 2 3 1 24 2 14 2 3 2 16 1 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 678 S 2 0 1 2 1 2 1 1 15 15 1 1 1 1 1 51 1 2 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 679 K 2 0 1 2 1 2 1 1 37 29 1 1 14 1 1 2 1 2 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 680 D 1 0 36 14 0 1 0 1 1 1 0 1 14 1 1 27 1 1 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 681 Q 1 0 1 1 0 1 0 1 1 1 0 14 1 60 15 1 1 1 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 682 M 1 0 1 1 0 1 0 1 1 27 36 1 14 1 1 1 1 14 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 683 Y 0 0 0 0 12 0 0 0 14 14 0 0 38 0 0 0 0 0 0 22 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 684 S 14 0 0 27 0 12 0 0 13 0 0 0 0 0 0 22 0 0 12 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 685 D 13 0 61 0 0 0 0 0 0 12 0 0 0 0 0 0 14 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 686 G 8 0 0 0 0 62 0 0 0 0 0 0 0 15 0 14 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 687 N 0 0 0 0 0 0 0 0 0 0 0 42 30 0 0 14 14 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 688 F 0 0 0 0 25 0 0 15 0 15 0 0 14 0 0 16 0 14 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 689 T 0 0 0 0 0 31 0 0 0 15 0 0 28 0 0 0 25 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 690 D 0 0 56 15 0 0 0 14 0 0 0 0 0 0 0 14 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 691 V 0 0 0 0 0 0 0 14 0 15 0 0 0 0 0 0 30 41 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 692 S 0 0 0 31 0 0 0 0 14 0 0 0 15 0 0 25 14 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 693 V 0 0 16 15 0 0 0 15 14 14 0 0 0 0 0 0 0 25 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 694 V 0 0 0 0 0 0 0 14 0 15 0 0 0 0 0 0 14 57 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 695 E 0 0 0 56 0 0 0 0 0 0 0 0 0 0 0 0 14 30 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 696 I 0 0 0 14 0 0 0 25 0 45 0 0 0 0 0 0 0 15 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 697 E 0 0 0 54 0 0 0 0 16 14 0 0 0 15 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 698 A 25 0 0 43 0 0 0 0 0 0 0 0 31 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 699 N 0 16 14 14 0 0 0 0 0 0 15 25 0 0 0 0 0 15 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 700 D 1 0 24 30 1 1 0 1 1 1 0 18 1 1 1 1 1 16 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 701 K 1 0 1 16 1 1 0 1 55 1 0 1 16 1 1 1 1 1 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 702 K 1 0 1 1 1 1 0 1 55 1 0 1 16 1 1 16 1 1 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 703 P 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 704 F 0 19 0 0 10 0 0 0 0 0 0 0 0 0 0 0 16 54 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 705 P 0 0 0 0 0 0 16 0 0 0 20 0 63 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 706 E 18 0 19 30 0 0 0 0 0 0 0 0 0 0 0 0 0 0 32 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 707 D 0 0 80 20 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 708 L 2 0 1 1 1 1 0 1 1 62 0 1 1 1 1 22 1 1 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 709 K 2 0 1 22 1 1 0 1 61 2 0 1 1 1 1 1 1 1 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 710 S 0 0 0 0 0 0 0 0 0 23 0 0 0 0 0 77 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 711 L 2 0 1 1 1 2 20 1 1 27 0 1 1 1 1 1 1 37 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 712 D 2 0 38 1 1 2 0 1 1 2 0 20 1 1 1 1 1 24 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 713 L 2 0 1 1 1 2 0 1 1 39 0 24 1 1 1 21 1 1 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 714 F 2 0 1 1 61 2 0 1 1 2 0 1 1 1 1 21 1 1 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 715 K 2 0 1 44 1 2 0 1 38 2 0 1 1 1 1 1 1 1 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 716 K 2 0 1 1 1 2 0 1 38 2 0 24 1 1 1 1 21 1 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 717 E 2 20 1 61 1 2 0 1 1 2 0 1 1 1 1 1 1 1 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 718 K 2 0 1 1 1 21 0 1 38 2 0 1 1 1 1 1 1 24 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 719 I 2 0 1 1 1 2 0 26 1 21 0 1 1 1 1 1 1 37 0 1 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 720 N 0 0 0 0 0 0 0 0 0 23 0 13 20 0 0 45 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 721 T 0 0 0 0 0 20 0 0 0 0 0 0 0 0 0 0 80 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 722 E 0 0 0 60 0 0 0 0 0 20 0 20 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 723 G 0 0 0 0 0 80 0 0 0 0 0 0 0 0 0 0 0 20 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 724 H 0 0 0 0 0 0 37 0 0 0 0 0 0 43 0 20 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 725 S 23 0 0 0 0 0 0 0 0 20 0 0 0 0 0 37 20 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 726 S 0 0 0 0 0 0 0 0 0 0 0 0 20 0 0 60 0 0 0 20 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 727 G 20 0 0 0 0 37 0 23 0 0 0 0 0 0 0 0 0 20 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 728 I 0 0 0 0 0 0 0 37 0 63 0 0 0 0 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 729 G 0 0 0 0 0 60 0 0 0 0 0 0 0 20 0 0 0 20 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 730 G 0 0 0 0 0 80 0 0 0 0 0 0 0 20 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 731 S 20 0 20 23 0 0 0 0 0 0 0 0 0 0 0 37 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 732 S 23 0 0 0 0 0 0 0 0 0 0 0 20 0 0 37 0 0 0 20 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 733 C 0 37 0 0 0 0 0 0 0 0 0 0 0 0 20 0 0 44 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 734 M 20 0 0 0 0 0 0 0 0 20 37 0 0 0 0 0 23 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 735 S 0 0 0 0 0 0 0 0 0 0 0 0 0 20 0 60 0 20 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 736 S 0 0 0 0 0 20 0 0 0 0 0 0 23 0 0 56 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 737 S 0 0 20 0 0 0 0 0 0 0 0 0 0 0 0 60 20 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 738 R 0 0 0 0 0 0 0 0 0 0 0 0 20 20 60 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 739 P 0 0 0 0 0 0 0 0 0 0 0 0 80 0 20 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 740 S 2 0 1 27 1 2 1 1 1 2 1 1 1 1 1 51 1 2 0 1 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 741 I 2 0 1 2 1 2 1 76 1 2 1 1 1 1 1 2 1 2 0 1 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 742 S 4 1 3 3 2 4 1 3 3 5 1 2 3 2 3 53 3 3 1 2 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 743 S 4 1 3 3 2 4 1 3 3 5 1 2 3 2 3 53 3 3 1 2 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 744 S 2 0 1 2 1 2 1 1 1 2 1 17 1 1 1 60 1 2 0 1 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 745 D 2 0 18 33 1 2 1 1 1 2 1 27 1 1 1 2 1 2 0 1 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 746 E 2 0 1 50 1 2 1 1 1 2 1 1 1 27 1 2 1 2 0 1 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 747 N 2 0 1 2 1 2 1 1 1 2 1 50 1 1 1 28 1 2 0 1 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 748 E 0 0 0 49 0 0 0 0 0 0 0 0 0 51 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 749 S 0 0 0 0 0 0 0 0 0 0 0 0 26 0 0 74 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 750 S 32 0 0 0 0 0 0 0 0 0 0 0 26 25 0 17 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 751 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 49 0 51 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 752 N 0 0 0 0 0 25 0 0 0 0 0 17 0 0 26 32 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 753 T 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 754 S 32 0 0 0 0 26 0 0 0 0 0 0 0 0 0 42 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 755 S 0 0 51 0 0 0 0 0 0 0 0 0 0 0 0 49 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 756 T 0 0 0 0 0 0 0 0 0 0 0 0 0 51 0 0 49 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 757 V 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 758 Q 0 0 0 0 0 0 0 0 0 51 0 0 0 49 0 0 0 0 0 0 COMPBIAS:/note="Polar residues":TOPO_DOM:/note="Cytoplasmic":COMPBIAS:/note="Polar residues":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 759 Y 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 MUTAGEN:/note="Y->F: Refractory to inhibition by SOCS3.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Y->F: Refractory to inhibition by SOCS3.":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 760 S 0 0 0 0 0 51 0 0 0 0 0 0 0 0 0 49 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 761 T 0 0 0 0 0 0 0 0 0 0 0 0 0 51 0 0 49 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 762 V 0 0 0 0 0 0 0 0 0 25 0 0 0 0 0 0 0 75 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 763 V 0 0 0 0 0 0 0 0 0 51 0 0 0 0 0 0 0 49 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 764 H 0 0 0 26 0 25 49 0 0 0 0 0 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 765 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 766 G 0 0 0 0 0 49 0 0 0 0 0 0 51 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 767 Y 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 51 0 0 49 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 768 R 0 0 0 0 0 0 0 0 0 0 0 0 0 0 49 51 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 769 H 4 1 3 3 2 4 50 3 3 5 1 2 3 2 3 4 3 3 1 2 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 770 Q 4 1 3 3 2 4 1 3 3 5 1 2 3 51 3 4 3 3 1 2 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 771 V 4 1 3 3 2 4 1 3 3 5 1 2 3 2 3 4 3 52 1 2 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 772 P 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 773 S 0 0 0 0 0 51 0 0 0 0 0 0 0 0 0 49 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 774 V 0 0 0 0 0 0 0 0 0 0 0 0 25 0 0 0 0 75 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 775 Q 0 0 0 0 0 25 0 0 0 0 26 0 0 49 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 776 V 0 0 0 0 0 0 25 0 0 0 0 0 0 26 0 0 0 49 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 777 F 0 0 0 0 49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 51 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 778 S 0 0 0 0 0 0 0 26 0 25 0 0 0 0 0 49 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 779 R 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 780 S 0 25 0 0 0 0 0 0 0 0 0 0 0 0 0 75 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 781 E 0 0 51 49 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 782 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MOD_RES:/note="Phosphoserine":MUTAGEN:/note="S->A: Increases cell surface expression.":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine":MUTAGEN:/note="S->A: Increases cell surface expression.":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 783 T 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 784 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 785 P 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 786 L 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 787 L 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 788 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 789 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MOD_RES:/note="Phosphoserine":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 790 E 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 791 E 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 792 R 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 793 P 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 794 E 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 795 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 796 L 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 797 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:TOPO_DOM:/note="Cytoplasmic" 798 L 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 799 V 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 800 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 801 H 0 0 0 0 0 0 35 0 0 0 0 0 0 0 0 65 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 802 V 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 803 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 804 G 0 0 0 0 0 68 0 0 0 0 0 0 0 0 0 32 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 805 G 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 806 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 807 G 0 0 0 65 0 35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 808 I 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 809 L 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 810 P 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 811 R 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 812 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 813 Q 0 0 0 0 0 0 0 0 0 0 0 0 33 67 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 814 Y 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 815 F 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 816 K 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 817 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 818 N 0 0 0 0 0 0 0 0 0 0 0 68 0 0 0 32 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 819 C 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 820 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 821 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 822 H 0 0 0 0 0 0 35 0 0 0 0 0 65 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 823 E 0 0 0 68 0 32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 824 S 65 0 0 0 0 0 0 0 0 0 0 0 0 0 0 35 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 825 S 0 33 0 0 0 0 0 0 0 0 0 0 0 0 0 67 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 826 P 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 827 D 0 0 67 33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 828 I 0 0 0 0 0 0 0 68 0 0 0 0 0 0 0 0 0 32 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 829 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MOD_RES:/note="Phosphoserine":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 830 H 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 831 F 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 832 E 0 0 0 68 0 32 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 833 R 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 834 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 835 K 0 0 0 0 0 0 0 0 35 0 0 33 0 0 0 32 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 836 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 837 V 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 838 S 0 0 0 0 0 0 0 0 0 33 0 0 32 0 0 35 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 839 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MOD_RES:/note="Phosphoserine":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MOD_RES:/note="Phosphoserine":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 840 V 0 0 0 0 0 65 0 0 0 0 0 0 0 0 0 0 0 35 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 841 N 0 0 0 0 0 0 0 0 0 0 0 68 0 0 0 32 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 842 E 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 843 E 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 844 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 845 F 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 846 V 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 847 R 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 848 L 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 849 K 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 850 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 851 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 852 I 0 0 0 0 0 0 0 35 0 0 0 0 0 0 0 0 0 65 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 853 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 854 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 855 H 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 856 I 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 857 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 858 Q 0 0 0 32 0 0 0 0 0 0 0 0 0 68 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 859 S 0 0 0 0 0 0 0 0 0 0 0 0 65 0 0 35 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 860 C 0 35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 65 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 861 G 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 862 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 863 G 0 0 0 65 0 35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 864 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 865 M 0 0 0 0 0 0 0 0 0 0 35 0 0 0 65 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 866 K 0 0 0 0 0 0 0 0 35 0 0 0 0 0 65 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 867 M 0 0 0 0 0 0 0 0 0 65 35 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 868 F 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 869 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 870 E 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 871 V 0 0 0 0 0 65 0 0 0 0 0 0 0 0 0 0 0 35 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 872 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 873 A 35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 33 32 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 874 A 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 875 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 876 A 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 877 F 0 0 0 0 35 0 0 0 0 65 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 878 G 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 879 P 0 0 0 0 0 0 0 0 0 0 0 0 35 0 0 0 65 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 880 G 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 881 T 33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 67 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 882 E 0 0 65 35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 883 G 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 884 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 885 V 0 0 0 0 0 0 0 32 0 0 33 0 0 0 0 0 0 35 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 886 E 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 887 R 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 888 F 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 889 E 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 890 T 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 65 35 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 891 V 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 892 G 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 893 M 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 894 E 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 895 A 35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 65 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 896 A 67 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 33 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 897 T 0 0 0 0 0 0 0 33 0 0 32 0 0 0 0 0 35 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 898 D 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 899 E 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 900 G 0 0 32 33 0 35 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 901 M 0 0 0 0 0 0 0 65 0 0 35 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 902 P 0 0 0 0 0 0 0 0 0 0 0 0 68 0 0 32 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 903 K 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 904 S 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 905 Y 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 906 L 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 907 P 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 908 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 909 T 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 910 V 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 911 R 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 912 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 913 G 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 914 G 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 915 Y 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 100 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 916 M 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 917 P 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic" 918 Q 0 0 0 0 0 0 0 0 0 0 0 0 0 100 0 0 0 0 0 0 MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic":DISORDER:predicted by DISOPRED:MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":MUTAGEN:/note="Missing: Results in impaired cytokine-mediated signaling pathway with loss of response to IL-6 and IL-11. Weak response to IL-27, OSM and LIF.":TOPO_DOM:/note="Cytoplasmic"